5,055 Matching Annotations
  1. Last 7 days
    1. CaseMYH7-10: Australia

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: See Table 1

      CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.

      Variant: NM_000257.3:c.3592G>T (p.Asp1198Tyr)

      ClinVar: 520451 https://www.ncbi.nlm.nih.gov/clinvar/variation/520451/

      gnomAD: Not in gnomAD

    2. CaseMYH7-36: Australia

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: See Table 1

      CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.

      Variant: NM_000257.3:c.1208G>A (p.Arg403Gln)

      ClinVar: 14087 https://www.ncbi.nlm.nih.gov/clinvar/variation/14087/

      gnomAD: Not in gnomAD

    3. CaseMYH7-24: Australia

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: See Table 1

      CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.

      Variant: NM_000257.3:c.2221G>T (p.Gly741Trp)

      ClinVar: 177665 https://www.ncbi.nlm.nih.gov/clinvar/variation/177665/

      gnomAD: Not in gnomAD

    4. CaseMYH7-6: Australia

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: 2 other probands have this genotype

      CasePreviousTesting: See Table 1

      CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.

      Variant: NM_000257.3:c.4135G>A (p.Ala1379Thr)

      ClinVar: 42993 https://www.ncbi.nlm.nih.gov/clinvar/variation/42993/

      gnomAD: Latino 2.822e-5, Overall 3.535e-6 https://gnomad.broadinstitute.org/variant/14-23887453-C-T

    5. CaseMYH7-31: Australia

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: 1 other proband shares this genotype

      CasePreviousTesting: See Table 1

      CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.

      Variant: NM_000257.3:c.1954A>G (p.Arg652Gly)

      ClinVar: 177626 https://www.ncbi.nlm.nih.gov/clinvar/variation/177626/

      gnomAD: Not in gnomAD

    6. CaseMYH7-37: Australia

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: See Table 1

      CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.

      Variant: NM_000257.3:c.1207C>T (p.Arg403Trp)

      ClinVar: 14102 https://www.ncbi.nlm.nih.gov/clinvar/variation/14102/

      gnomAD: Not in gnomAD

    7. CaseMYH7-13: Australia

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: See Table 1

      CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.

      Variant: NM_000257.3:c.3064A>G (p.Lys1022Glu)

      CAID: CA389045738 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000257.3%3Ac.3064A%3EG

      gnomAD: Not in gnomAD

    8. CaseMYH7-18: Australia

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: See Table 1

      CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.

      Variant: NM_000257.3:c.2578A>G (p.Lys860Glu)

      ClinVar: 192312 https://www.ncbi.nlm.nih.gov/clinvar/variation/192312/

      gnomAD: Not in gnomAD

    9. CaseMYH7-2: Australia

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: See Table 1

      CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.

      Variant: NM_000257.3:c.5287G>A (p.Ala1763Thr)

      ClinVar: 177846 https://www.ncbi.nlm.nih.gov/clinvar/variation/177846/

      gnomAD: European (Non-Finnish) 1.238e-4, Overall 7.423e-5 https://gnomad.broadinstitute.org/variant/14-23884476-C-T

    1. 21

      CaseVI: Brazil, Caucasian

      DiseaseAssertion: Hypertrophic cardiomyopathy

      FamilyInfo: Family history of HCM

      CasePresentingHPOs: HP:0001712, HP:0001639 (Left ventricular hypertrophy, Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: Only MYH7, MYBPC3, and TNNT2 were tested.

      CaseGenotypingMethod: DNA was extracted from peripheral blood and the above genes were subject to PCR amplification and directly sequenced. The resulting sequences were compared with the reference and filtered for pathogenicity.

      Variant: NM_000257.3:c.2389G>A (p.Ala797Thr)

      ClinVar: 42901 https://www.ncbi.nlm.nih.gov/clinvar/variation/42901/

      gnomAD: African 1.230e-4, Overall 2.386e-5 https://gnomad.broadinstitute.org/variant/14-23894525-C-T

    1. HCM1.1

      CaseHCM1.1: Indian

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: HP:0000819 (Diabetes mellitus)

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: See Table 1

      CaseGenotypingMethod: DNA was extracted from the probands' blood, followed by sequencing of the coding regions and exon/intron boundaries of 15 genes associated with HCM. From there, they were amplified by PCR ampliication and variants were filtered by pathogenicity. Every unclassified variant was confirmed by Sanger sequencing afterwards.

      Variant: NM_000257.3:c.611G>A (p.Arg204His)

      ClinVar: 43095 https://www.ncbi.nlm.nih.gov/clinvar/variation/43095/

      gnomAD: East Asian 5.012e-5, Overall 1.767e-5 https://gnomad.broadinstitute.org/variant/14-23900998-C-T

    2. HCM34.1

      CaseHCM34.1: Mixed ancestry

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: HP:0000819 (Diabetes mellitus)

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: See Table 1

      CaseGenotypingMethod: DNA was extracted from the probands' blood, followed by sequencing of the coding regions and exon/intron boundaries of 15 genes associated with HCM. From there, they were amplified by PCR ampliication and variants were filtered by pathogenicity. Every unclassified variant was confirmed by Sanger sequencing afterwards.

      Variant: NM_000257.3:c.1357C>T (p.Arg453Cys)

      ClinVar: 14089 https://www.ncbi.nlm.nih.gov/clinvar/variation/14089/

      gnomAD: Not in gnomAD

    3. HCM14.1

      CaseHCM14.1: Mixed ancestry

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: HP:0000819 (Diabetes mellitus)

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: See Table 1

      CaseGenotypingMethod: DNA was extracted from the probands' blood, followed by sequencing of the coding regions and exon/intron boundaries of 15 genes associated with HCM. From there, they were amplified by PCR ampliication and variants were filtered by pathogenicity. Every unclassified variant was confirmed by Sanger sequencing afterwards.

      Variant: NM_000257.3:c.2167C>T (p.Arg723Cys)

      ClinVar: 14095 https://www.ncbi.nlm.nih.gov/clinvar/variation/14095/

      gnomAD: South Asian 3.266e-5, Overall 1.194e-5 https://gnomad.broadinstitute.org/variant/14-23895023-G-A

    1. Case427: Female, 1.5 years onset, Japan, Asian

      DiseaseAssertion: Left ventricular noncompaction

      FamilyInfo: Father has DCM

      CasePresentingHPOs: HP:0030682, HP:0025169 (Left ventricular noncompaction, Left ventricular systolic dysfunction)

      HPOsFreeText: Left Ventricular Ejection Fraction at 44.1%, LVDD-Z score at 1.3709

      CaseNotHPOs: HP:0011675, HP:0001635 (Arrhythmia, Heart failure)

      NotHPOsFreeText: Congenital heart disease with significant hemodynamic changes

      CaseAddInfo:


      CasePreviousTesting: Genes tested include the 8 sarcomere genes as well as 65 more listed in Table S1.

      CaseGenotypingMethod: Genomic DNA was extracted from whole blood from each of the probands. Next Generation Sequencing of 73 genes related to cardiac function was performed, incorporating PCR amplification, and any variants found were subjected to filtering for frequency and pathogenicity. Any variants suggested to be pathogenic were confirmed by Sanger sequencing afterwards.


      Variant: NM_000257.3:c.2821C>T (p.Arg941Cys)

      CAID: CA389046936 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000257.3:c.2821C%3ET

      gnomAD: Not in gnomAD

    2. Case392: Male, 0.083 years onset, Japan, Asian

      DiseaseAssertion: Left ventricular noncompaction

      CasePresentingHPOs: HP:0030682, HP:0025169, HP:0001635 (Left ventricular noncompaction, Left ventricular systolic dysfunction, Heart failure)

      HPOsFreeText: Left Ventricular Ejection Fraction at 29%, LVDD-Z score at 2.1428

      CaseNotHPOs: HP:0011675 (Arrhythmia)

      NotHPOsFreeText: Congenital heart disease with significant hemodynamic changes

      CaseAddInfo: No family history


      CasePreviousTesting: Genes tested include the 8 sarcomere genes as well as 65 more listed in Table S1.

      CaseGenotypingMethod: Genomic DNA was extracted from whole blood from each of the probands. Next Generation Sequencing of 73 genes related to cardiac function was performed, incorporating PCR amplification, and any variants found were subjected to filtering for frequency and pathogenicity. Any variants suggested to be pathogenic were confirmed by Sanger sequencing afterwards.


      Variant: NM_000257.3:c.944A>G (p.Gln315Arg)

      CAID: CA389051698 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000257.3:c.944A%3EG

      gnomAD: Not in gnomAD

    3. Case378: Female, Birth onset, Japan, Asian

      DiseaseAssertion: Left ventricular noncompaction

      FamilyInfo: Sister has LVNC

      CasePresentingHPOs: HP:0030682, HP:0025169, HP:0001635, HP:0005110 (Left ventricular noncompaction, Left ventricular systolic dysfunction, Heart failure, Atrial fibrillation)

      HPOsFreeText: Left Ventricular Ejection Fraction at 20%, LVDD-Z score at 0.1

      CaseNotHPOs: N/A

      NotHPOsFreeText: Congenital heart disease with significant hemodynamic changes

      CaseAddInfo:


      CasePreviousTesting: Genes tested include the 8 sarcomere genes as well as 65 more listed in Table S1.

      CaseGenotypingMethod: Genomic DNA was extracted from whole blood from each of the probands. Next Generation Sequencing of 73 genes related to cardiac function was performed, incorporating PCR amplification, and any variants found were subjected to filtering for frequency and pathogenicity. Any variants suggested to be pathogenic were confirmed by Sanger sequencing afterwards.


      Variant: NM_000257.3:c.1859T>C (p.Leu620Pro)

      CAID: CA389049669 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000257.3:c.1859T%3EC

      gnomAD: Not in gnomAD

    4. Case298: Female, 6 years onset, Japan, Asian

      DiseaseAssertion: Left ventricular noncompaction

      CasePresentingHPOs: HP:0030682 (Left ventricular noncompaction)

      HPOsFreeText: Left Ventricular Ejection Fraction at 65%, LVDD-Z score at 2.1

      CaseNotHPOs: HP:0011675 (Arrhythmia)

      NotHPOsFreeText: Congenital heart disease with significant hemodynamic changes

      CaseAddInfo: No family history


      CasePreviousTesting: Genes tested include the 8 sarcomere genes as well as 65 more listed in Table S1.

      CaseGenotypingMethod: Genomic DNA was extracted from whole blood from each of the probands. Next Generation Sequencing of 73 genes related to cardiac function was performed, incorporating PCR amplification, and any variants found were subjected to filtering for frequency and pathogenicity. Any variants suggested to be pathogenic were confirmed by Sanger sequencing afterwards.


      Variant: NM_000257.3:c.2710C>T (p.Arg904Cys)

      ClinVar: 164316 https://www.ncbi.nlm.nih.gov/clinvar/variation/164316/

      gnomAD: Ashkenazi Jewish 9.921e-5, Overall 3.977e-6 https://gnomad.broadinstitute.org/variant/14-23893328-G-A

    1. III-3

      Case III-3: Female, 6yo

      DiseaseAssertion: Left ventricular hypertrophy

      CasePresentingHPOs: HP:0001712 (left ventricular hypertrophy)

      CaseHPOFreeText: double-chambered left ventricle, asymptomatic, normal thickness of septum and left ventricle, left ventricle ventricle end-diastolic diameter = 53.5mm, left ventricular ejection fraction = 64%

      CasePreviousTesting: same as proband

      CaseGenotypingMethod: Affymetrix Cytoscan 750K Array to check potential candidate copy number variations, segregation analysis using the results from Sanger sequencing

      Variant: NM_000257.3:c.998A>T

      CAID: CA389051586, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA389051586

      gnomAD: n/a

    1. CaseMYH7-22: N/A

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CaseGenotypingMethod: Testing for all 8 sarcomeric genes, plus GLA, LAMP2, and PRKAG2 was initiated in all probands. After the direct sequencing, the variants were filtered for pathogenicity and classified.

      Variant: NM_000257.3:c.2788G>A (p.Glu930Lys)

      ClinVar: 42933 https://www.ncbi.nlm.nih.gov/clinvar/variation/42933/

      gnomAD: Not in gnomAD

    2. CaseMYH7-26: N/A

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CaseGenotypingMethod: Testing for all 8 sarcomeric genes, plus GLA, LAMP2, and PRKAG2 was initiated in all probands. After the direct sequencing, the variants were filtered for pathogenicity and classified.

      Variant: NM_000257.3:c.2609G>A (p.Arg870His)

      ClinVar: 14120 https://www.ncbi.nlm.nih.gov/clinvar/variation/14120/

      gnomAD: European (Non-Finnish) 1.549e-5, Overall 7.072e-6 https://gnomad.broadinstitute.org/variant/14-23894048-C-T

    3. CaseMYH7-1: N/A

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CaseGenotypingMethod: Testing for all 8 sarcomeric genes, plus GLA, LAMP2, and PRKAG2 was initiated in all probands. After the direct sequencing, the variants were filtered for pathogenicity and classified.

      Variant: NM_000257.3:c.1987C>T (p.Arg663Cys)

      ClinVar: 42874 https://www.ncbi.nlm.nih.gov/clinvar/variation/42874/

      gnomAD: Not in gnomAD

    4. CaseMYH7-13: N/A

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CaseGenotypingMethod: Testing for all 8 sarcomeric genes, plus GLA, LAMP2, and PRKAG2 was initiated in all probands. After the direct sequencing, the variants were filtered for pathogenicity and classified.

      Variant: NM_000257.3:c.1208G>A (p.Arg403Gln)

      ClinVar: 14087 https://www.ncbi.nlm.nih.gov/clinvar/variation/14087/

      gnomAD: Not in gnomAD

    5. CaseMYH7-5: N/A

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CaseGenotypingMethod: Testing for all 8 sarcomeric genes, plus GLA, LAMP2, and PRKAG2 was initiated in all probands. After the direct sequencing, the variants were filtered for pathogenicity and classified.

      Variant: NM_000257.3:c.2198G>T (p.Gly733Val)

      ClinVar: 181177 https://www.ncbi.nlm.nih.gov/clinvar/variation/181177/

      gnomAD: Not in gnomAD

    6. CaseMYH7-2: N/A

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CaseGenotypingMethod: Testing for all 8 sarcomeric genes, plus GLA, LAMP2, and PRKAG2 was initiated in all probands. After the direct sequencing, the variants were filtered for pathogenicity and classified.

      Variant: NM_000257.3:c.5135G>A (p.Arg1712Gln)

      ClinVar: 36642 https://www.ncbi.nlm.nih.gov/clinvar/variation/36642/

      gnomAD: European (Non-Finnish) 4.657e-5, Overall 2.125e-5 https://gnomad.broadinstitute.org/variant/14-23884860-C-T

    1. CaseHCM133: 64 yrs report, Vietnam, Asian

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: Family history of sudden cardiac death

      CasePresentingHPOs: HP:0100749, HP:0001712, HP:0031295 (Chest pain, Left ventricular hypertrophy, Left atrial enlargement)

      HPOsFreeText: Maximal LV thickness 21 mm

      CaseNotHPOs: HP:0005110, HP:0001297, HP:0004756 (Atrial fibrillation, Stroke, Ventricular tachycardia)

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: The gene panel included 10 sarcomeric genes (MYH7, MYBPC3, TNNT2, TNNI3, TPM1, MYL2, MYL3, ACTC1, TNNC1, MYH6), 9 genes encoding Z-disk components and Ca2+ homeostasis factors (LDB3, CSRP3, TCAP, VCL, ACTN2, MYOZ2, NEXN, JPH2, PLN), and 4 genes involved in HCM phenocopies (GLA, LAMP2, PRKAG2, TTR), All probands had left ventricular wall thickness >= 15 mm and no other diseases that can cause secondary hypertrophy

      CaseGenotypingMethod: The coding region, flanking sequences, and untranslated regions of each gene were enriched by LC-PCR, amplified, and sequenced on the Illumina MiSeq or MiniSeq platform. Identified variants were then filtered for pathogenicity and confirmed by Sanger sequencing.

      Variant: NM_000257.4(MYH7):c.3551A>T (p.Gln1184Leu)

      ClinVar: 181226 https://www.ncbi.nlm.nih.gov/clinvar/variation/181226/

      gnomAD: 0.0006115, http://gnomad.broadinstitute.org/variant/14-23889229-T-A

      Multiple Gene Variants

      (1) MYH6 Variant

      Variant: NM_002471.3(MYH6):c.1252G>A (p.Val418Met)

      ClinVar: 44449 https://www.ncbi.nlm.nih.gov/clinvar/variation/44449/

      gnomAD: 0.001954, http://gnomad.broadinstitute.org/variant/14-23870076-C-T

    2. CaseHCM083: 53 yrs report, Vietnam, Asian

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0002875, HP:0001712, HP:0001667, HP:0001705 (Exertional dyspnea, Left ventricular hypertrophy, Right ventricular hypertrophy, Right ventricular outlet obstruction)

      HPOsFreeText: Maximal LV thickness 18 mm

      CaseNotHPOs: HP:0005110, HP:0001297, HP:0004756 (Atrial fibrillation, Stroke, Ventricular tachycardia)

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: The gene panel included 10 sarcomeric genes (MYH7, MYBPC3, TNNT2, TNNI3, TPM1, MYL2, MYL3, ACTC1, TNNC1, MYH6), 9 genes encoding Z-disk components and Ca2+ homeostasis factors (LDB3, CSRP3, TCAP, VCL, ACTN2, MYOZ2, NEXN, JPH2, PLN), and 4 genes involved in HCM phenocopies (GLA, LAMP2, PRKAG2, TTR), All probands had left ventricular wall thickness >= 15 mm and no other diseases that can cause secondary hypertrophy

      CaseGenotypingMethod: The coding region, flanking sequences, and untranslated regions of each gene were enriched by LC-PCR, amplified, and sequenced on the Illumina MiSeq or MiniSeq platform. Identified variants were then filtered for pathogenicity and confirmed by Sanger sequencing.

      Variant: NM_000257.4(MYH7):c.4159G>A (p.Glu1387Lys)

      ClinVar: 181244 https://www.ncbi.nlm.nih.gov/clinvar/variation/181244/

      gnomAD: 0.00003266, http://gnomad.broadinstitute.org/variant/14-23887429-C-T

    3. CaseHCM051: 39 yrs report, Vietnam, Asian

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: Family history of hypertrophic cardiomyopathy, Has 2 siblings where the MYH7 and MYOZ2 mutations are solely present in the brother and sister respectively, Brother has LVH and palpitations while sister has no symptoms whatsoever

      CasePresentingHPOs: HP:0100749, HP:0001712, HP:0031295 (Chest pain, Left ventricular hypertrophy, Left atrial enlargement)

      HPOsFreeText: Maximal LV thickness 18 mm

      CaseNotHPOs: HP:0005110, HP:0001297, HP:0004756 (Atrial fibrillation, Stroke, Ventricular tachycardia)

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: The gene panel included 10 sarcomeric genes (MYH7, MYBPC3, TNNT2, TNNI3, TPM1, MYL2, MYL3, ACTC1, TNNC1, MYH6), 9 genes encoding Z-disk components and Ca2+ homeostasis factors (LDB3, CSRP3, TCAP, VCL, ACTN2, MYOZ2, NEXN, JPH2, PLN), and 4 genes involved in HCM phenocopies (GLA, LAMP2, PRKAG2, TTR), All probands had left ventricular wall thickness >= 15 mm and no other diseases that can cause secondary hypertrophy

      CaseGenotypingMethod: The coding region, flanking sequences, and untranslated regions of each gene were enriched by LC-PCR, amplified, and sequenced on the Illumina MiSeq or MiniSeq platform. Identified variants were then filtered for pathogenicity and confirmed by Sanger sequencing.

      Variant: NM_000257.4(MYH7):c.3424G>A (p.Glu1142Lys)

      ClinVar: 181222 https://www.ncbi.nlm.nih.gov/clinvar/variation/181222/

      gnomAD: Not in gnomAD

      Multiple Gene Variants

      (1) MYOZ2 Variant

      Variant: NM_016599.4:c.326C>G (p.Pro109Arg)

      CAID: CA104971226 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA104971226

      gnomAD: Not in gnomAD

    1. Supplementary Data: S2 Table

      Case 193: Spanish, 47yo, Male

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      CasePreviousTesting: Full Testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplementary data table S1

      CaseGenotypingMethod: genomic DNA obtained from blood or saliva, Next-gen sequencing panels of 55 or 78 genes

      Variant: NM_000257.3(MYH7):c.2389G>A (p.Ala797Thr)

      ClinVar: 42901, https://www.ncbi.nlm.nih.gov/clinvar/variation/42901/

      gnomAD: 0.00002386, https://gnomad.broadinstitute.org/variant/14-23894525-C-T

    2. Supplementary Data: S2 Table

      Case 121: Spanish, 23yo, Male

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      CasePreviousTesting: Full Testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplementary data table S1

      CaseGenotypingMethod: genomic DNA obtained from blood or saliva, Next-gen sequencing panels of 55 or 78 genes

      Variant: NM_000257.3(MYH7):c.2221G>C (p.Gly741Arg)

      ClinVar: 14098, https://www.ncbi.nlm.nih.gov/clinvar/variation/14098/

      gnomAD: n/a

      MultipleGeneVariants:

      (1) TTN Variants:

      Variant1: NM_133378.4(TTN):c.52301A>G

      ClinVar: 47157, https://www.ncbi.nlm.nih.gov/clinvar/variation/47157/

      gnomAD: 0.0005511, https://gnomad.broadinstitute.org/variant/2-179456541-T-C

      Variant2: NM_133378.4:c.50516C>G

      CAID: CA349508241, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_133378.4%3Ac.50516C%3EG

      gnomAD: n/a

    3. Supplementary Data: S2 Table

      Case 160: Spanish, 67yo, Female

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      CasePreviousTesting: Full Testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplementary data table S1

      CaseGenotypingMethod: genomic DNA obtained from blood or saliva, Next-gen sequencing panels of 55 or 78 genes

      Variant: NM_000257.3(MYH7):c.2389G>A (p.Ala797Thr)

      ClinVar: 42901, https://www.ncbi.nlm.nih.gov/clinvar/variation/42901/

      gnomAD: 0.00002386, https://gnomad.broadinstitute.org/variant/14-23894525-C-T

      MultipleGeneVariants:

      (1) TTN Variant:

      Variant: NM_133378.4:c.78641C>T

      CAID: CA1988519, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_133378.4%3Ac.78641C%3ET

      gnomAD: 0.00001646, https://gnomad.broadinstitute.org/variant/2-179424514-G-A

    4. Supplementary Data: S2 Table

      Case 2: Spanish, 14yo, Male

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      CasePreviousTesting: Full Testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplementary data table S1

      CaseGenotypingMethod: genomic DNA obtained from blood or saliva, PCR, Sanger Sequencing

      Variant: NM_000257.3(MYH7):c.1012G>A (p.Val338Met)

      ClinVar: 164381, https://www.ncbi.nlm.nih.gov/clinvar/variation/164381/

      gnomAD: n/a

    5. Supplementary Data: S2 Table

      Case 49: Spanish, 18yo, Male

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      CasePreviousTesting: Full Testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplementary data table S1

      CaseGenotypingMethod: genomic DNA obtained from blood or saliva, Next-gen sequencing panels of 55 or 78 genes

      Variant1: NM_000257.3(MYH7):c.2890G>C (p.Val964Leu)

      ClinVar: 42938, https://www.ncbi.nlm.nih.gov/clinvar/variation/42938/

      gnomAD: 0.0004383, https://gnomad.broadinstitute.org/variant/14-23893148-C-G

      Variant2: NM_000257.3(MYH7):c.3613G>A (p.Glu1205Lys)

      ClinVar: 179656, https://www.ncbi.nlm.nih.gov/clinvar/variation/179656/

      gnomAD: 0.000004004, https://gnomad.broadinstitute.org/variant/14-23889167-C-T

    1. Supplementary Data: Table 2

      Case 1:

      DiseaseAssertion: Dilated Cardiomyopathy

      CasePresentingHPOs: HP:0001644 (dilated cardiomyopathy)

      CasePreviousTesting: 12-lead electrocardiogram (ECG), echocardiography, exercise test and 24-hour (or 48-hour) Holter monitoring, cardiac MRI, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplemental table 2

      CaseGenotypingMethod: WES, Cytoscan HD SNP array (performed on proband, 3 additional carriers, and parents)

      Variant 1 - maternal: NM_000257.2(MYH7):c.5754C>R (p.Asn1918Lys)

      ClinVar: 66082, https://www.ncbi.nlm.nih.gov/clinvar/variation/66082/

      gnomAD: n/a

      Variant 2 - paternal: NM_000257.3:c.328G>A

      CAID: CA036654, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA036654

      gnomAD: 0.00001591, https://gnomad.broadinstitute.org/variant/14-23902310-C-T

      MultipleGeneVariants:

      (1) FHL1 Variant:

      Variant (maternal): NM_001159702.2:c.968C>T

      CAID: CA10525127, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA10525127

      gnomAD: 0.000005449, https://gnomad.broadinstitute.org/variant/X-135292109-C-T

      (2) SYNE1 Variant:

      Variant (maternal): NM_033071.3(SYNE1):c.18514G>A (p.Glu6172Lys)

      ClinVar: 199251, https://www.ncbi.nlm.nih.gov/clinvar/variation/199251/

      gnomAD: 0.00003536, https://gnomad.broadinstitute.org/variant/6-152589279-C-T

    2. Supplementary Data: Table 2

      Case I: proband, Male

      DiseaseAssertion: Dilated Cardiomyopathy

      CasePresentingHPOs: HP:0001644 (dilated cardiomyopathy)

      CasePreviousTesting: 12-lead electrocardiogram (ECG), echocardiography, exercise test and 24-hour (or 48-hour) Holter monitoring, cardiac MRI, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplemental table 2

      CaseGenotypingMethod: genomic DNA isolated from peripheral blood, initially analyzed via Sanger Sequencing then by next-generation sequencing using targeted gene panels, variant pathogenicity assed using in silico prediction tools, Haplotype analysis was performed using 16 microsatellite markers around MYH7 (DNA from the 14 probands was analysed, and DNA samples of 6 family members carrying the mutation were used to verify the phase and reconstruct the haplotype Supplementary Data: Table 1)

      Variant: NM_000257.2(MYH7):c.5754C>R (p.Asn1918Lys)

      ClinVar: 66082, https://www.ncbi.nlm.nih.gov/clinvar/variation/66082/

      gnomAD: n/a

    1. Supplementary Data Table S3

      Case: 145

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant1: NM_000257.4(MYH7):c.1816G>A (p.Val606Met)

      ClinVar: 14091 https://www.ncbi.nlm.nih.gov/clinvar/variation/14091/

      gnomAD: 0.00001548, https://gnomad.broadinstitute.org/variant/14-23896866-C-T

      Variant2: NM_000257.4(MYH7):c.3853+7C>T

      ClinVar: 42977 https://www.ncbi.nlm.nih.gov/clinvar/variation/42977/

      gnomAD: 0.003956, https://gnomad.broadinstitute.org/variant/14-23888685-G-A

      MultipleGeneVariants:

      (1) SDHA Variant

      Variant: NM_004168.4(SDHA):c.1886A>T (p.Tyr629Phe)

      ClinVar: 224949 https://www.ncbi.nlm.nih.gov/clinvar/variation/224949/

      gnomAD: 0.5249, https://gnomad.broadinstitute.org/variant/5-254599-A-T

      (2) TMPO Variant

      Variant: NM_001032283.2(TMPO):c.859G>C (p.Ala287Pro)

      ClinVar: 43693 https://www.ncbi.nlm.nih.gov/clinvar/variation/43693/

      gnomAD: 0.04732, https://gnomad.broadinstitute.org/variant/12-98938295-G-C

    2. Supplementary Data Table S3

      Case: 355

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.2945T>C (p.Met982Thr)

      ClinVar: 42941 https://www.ncbi.nlm.nih.gov/clinvar/variation/42941/

      gnomAD: 0.001416, https://gnomad.broadinstitute.org/variant/14-23892910-A-G

      MultipleGeneVariants:

      (1) MYBPC3 Variant

      Variant: NM_000256.3(MYBPC3):c.3413G>A (p.Arg1138His)

      ClinVar: 177689 https://www.ncbi.nlm.nih.gov/clinvar/variation/177689/

      gnomAD: 0.01063, https://gnomad.broadinstitute.org/variant/11-47354442-C-T

    3. Supplementary Data Table S3

      Case: 52

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.2451C>A (p.Asn817Lys)

      ClinVar: 235029, https://www.ncbi.nlm.nih.gov/clinvar/variation/235029/

      gnomAD: absent

      MultipleGeneVariants:

      (1) TTN Variant

      Variant: NM_001267550.2(TTN):c.74597_74599CAA[1] (p.Thr24867del)

      ClinVar: 165840, https://www.ncbi.nlm.nih.gov/clinvar/variation/165840/

      gnomAD: absent

    4. Supplementary Data Table S3

      Case: 19

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.3158G>A (p.Arg1053Gln)

      ClinVar: 155814, https://www.ncbi.nlm.nih.gov/clinvar/variation/155814/

      gnomAD: 0.00006010, https://gnomad.broadinstitute.org/variant/14-23891476-C-T

    5. Supplementary Data Table S3

      Case: 256

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.3853+7C>T

      ClinVar: 42977 https://www.ncbi.nlm.nih.gov/clinvar/variation/42977/

      gnomAD: 0.003956, https://gnomad.broadinstitute.org/variant/14-23888685-G-A

      MultipleGeneVariants:

      (1) PLB1 Variant

      Variant: NM_153021.4:c.275A>G (p.Lys92Arg)

      CAID: CA1586810 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_153021.5%3Ac.275A%3EG

      gnomAD: 0.03209, https://gnomad.broadinstitute.org/variant/2-28748165-A-G

      (2) RBM20 Variant

      Variant: NM_001134363.3(RBM20):c.2662G>A (p.Asp888Asn)

      ClinVar: 43995 https://www.ncbi.nlm.nih.gov/clinvar/variation/43995/

      gnomAD: 0.02090, https://gnomad.broadinstitute.org/variant/10-112581039-G-A

    6. Supplementary Data Table S3

      Case: 353

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.3158G>A (p.Arg1053Gln)

      ClinVar: 155814 https://www.ncbi.nlm.nih.gov/clinvar/variation/155814/

      gnomAD: 0.0006368, https://gnomad.broadinstitute.org/variant/14-23891476-C-T

      MultipleGeneVariants:

      (1) EYA4 Variant

      Variant: NM_004100.5(EYA4):c.979G>A (p.Asp327Asn)

      ClinVar: 191664 https://www.ncbi.nlm.nih.gov/clinvar/variation/191664/

      gnomAD: 0.004341, https://gnomad.broadinstitute.org/variant/6-133802609-G-A

      (2) TTN Variant

      Variant: NM_133378.4:c.21031G>T (p.Glu7011Ter)

      CAID: CA349496727 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_133378.4%3Ac.21031G%3ET

      gnomAD: Not in gnomAD

    7. Supplementary Data Table S3

      Case: 46

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.3158G>A (p.Arg1053Gln)

      ClinVar: 155814, https://www.ncbi.nlm.nih.gov/clinvar/variation/155814/

      gnomAD: 0.00006010, https://gnomad.broadinstitute.org/variant/14-23891476-C-T

      MultipleGeneVariants:

      (1) EYA4 Variant

      Variant: NM_004100.5(EYA4):c.1495G>A (p.Val499Ile)

      ClinVar: 534385, https://www.ncbi.nlm.nih.gov/clinvar/variation/534385/

      gnomAD: 0.0002548, https://gnomad.broadinstitute.org/variant/6-133834170-G-A

      (2) FKTN Variant

      Variant: NM_006731.2(FKTN):c.1297A>G (p.Thr433Ala)

      ClinVar: 36137, https://www.ncbi.nlm.nih.gov/clinvar/variation/36137/

      gnomAD: 0.002206, https://gnomad.broadinstitute.org/variant/9-108397456-A-G

    1. CaseCM1871: Male, 0 years diagnosis, Japan, Asian

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: HP:0001939 (Abnormality of metabolism/homeostasis)

      NotHPOsFreeText: Neuromuscular disease, Malformation syndromes

      CaseAddInfo: No family history of cardiomyopathy or sudden death, Proband found in Supplementary Table 2, Mother shows negative for this variant with no symptoms


      CasePreviousTesting: 8 patients with HCM and one with RCM were analyzed by NGS for the eight sarcomere-encoding genes and MYP.

      CaseGenotypingMethod: Probands were subject to PCR amplification and direct sequencing of 64 cardiomyopathy-associated genes, including the eight sarcomere-encoding genes. The variants were then filtered for rarity and tested for pathogenicity.


      Variant: NM_000257.3:c.2608C>T (p.Arg870Cys)

      ClinVar: 161326 https://www.ncbi.nlm.nih.gov/clinvar/variation/161326/

      gnomAD: Ashkenazi Jewish 9.923e-5, Overall 2.386e-5 https://gnomad.broadinstitute.org/variant/14-23894049-G-A

    2. CaseCM1844: Male, 6 years diagnosis, Japan, Asian

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: HP:0001939 (Abnormality of metabolism/homeostasis)

      NotHPOsFreeText: Neuromuscular disease, Malformation syndromes

      CaseAddInfo: No family history of cardiomyopathy or sudden death, Proband found in Supplementary Table 2, Mother and father are both negative for this variant


      CasePreviousTesting: 8 patients with HCM and one with RCM were analyzed by NGS for the eight sarcomere-encoding genes and MYP.

      CaseGenotypingMethod: Probands were subject to PCR amplification and direct sequencing of 64 cardiomyopathy-associated genes, including the eight sarcomere-encoding genes. The variants were then filtered for rarity and tested for pathogenicity.


      Variant: NM_000257.3:c.1357C>T (p.Arg453Cys)

      ClinVar: 14089 https://www.ncbi.nlm.nih.gov/clinvar/variation/14089/

      gnomAD: Not in gnomAD

    3. CaseCM0969: Male, 6 years diagnosis, Japan, Asian

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: HP:0001939 (Abnormality of metabolism/homeostasis)

      NotHPOsFreeText: Neuromuscular disease, Malformation syndromes

      CaseAddInfo: Positive family history of cardiomyopathy or sudden death, Proband found in Supplementary Table 2, Variant is asserted as novel, Both father and sister with HCM tested positive for this variant


      CasePreviousTesting: 8 patients with HCM and one with RCM were analyzed by NGS for the eight sarcomere-encoding genes and MYP.

      CaseGenotypingMethod: Probands were subject to PCR amplification and direct sequencing of 64 cardiomyopathy-associated genes, including the eight sarcomere-encoding genes. The variants were then filtered for rarity and tested for pathogenicity.


      Variant: NM_000257.3:c.2777T>C (p.Leu926Pro)

      ClinVar: 525005 https://www.ncbi.nlm.nih.gov/clinvar/variation/525005/

      gnomAD: Not in gnomAD

    1. CasePT-38: United States

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: HP:0001650, HP:0001658 (Aortic valve stenosis, Myocardial infarction)

      NotHPOsFreeText: N/A

      CaseAddInfo: Two other siblings have the same genotype


      CaseGenotypingMethod: DNA was collected from the participants using blood samples. 18 genes suspected on contributing to HCM were targeted and sequenced. The variants were then located and filtered for pathogenicity.


      Variant: NM_000257.3:c.727C>T (p.Arg243Cys)

      ClinVar: 43101 https://www.ncbi.nlm.nih.gov/clinvar/variation/43101/

      gnomAD: European (Non-Finnish) 6.482e-5, Overall 3.184e-5 https://gnomad.broadinstitute.org/variant/14-23900799-G-A

    2. CasePT-30: United States

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: HP:0001650, HP:0001658 (Aortic valve stenosis, Myocardial infarction)

      NotHPOsFreeText: N/A

      CaseAddInfo:


      CaseGenotypingMethod: DNA was collected from the participants using blood samples. 18 genes suspected on contributing to HCM were targeted and sequenced. The variants were then located and filtered for pathogenicity.


      Variant: NM_000257.3:c.2606G>A (p.Arg869His)

      ClinVar: 177667 https://www.ncbi.nlm.nih.gov/clinvar/variation/177667/

      gnomAD: African 1.230e-4, Overall 2.386e-5 https://gnomad.broadinstitute.org/variant/14-23894051-C-T

    3. CasePT-76: United States

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: HP:0001650, HP:0001658 (Aortic valve stenosis, Myocardial infarction)

      NotHPOsFreeText: N/A

      CaseAddInfo:


      CaseGenotypingMethod: DNA was collected from the participants using blood samples. 18 genes suspected on contributing to HCM were targeted and sequenced. The variants were then located and filtered for pathogenicity.


      Variant: NM_000257.3:c.2334C>G (p.Asp778Glu)

      ClinVar: 265252 https://www.ncbi.nlm.nih.gov/clinvar/variation/265252/

      gnomAD: Not in gnomAD

    4. CasePT-97: United States

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: HP:0001650, HP:0001658 (Aortic valve stenosis, Myocardial infarction)

      NotHPOsFreeText: N/A

      CaseAddInfo:


      CaseGenotypingMethod: DNA was collected from the participants using blood samples. 18 genes suspected on contributing to HCM were targeted and sequenced. The variants were then located and filtered for pathogenicity.


      Variant: NM_000257.3:c.4159G>A (p.Glu1387Lys)

      ClinVar: 181244 https://www.ncbi.nlm.nih.gov/clinvar/variation/181244/

      gnomAD: South Asian 3.266e-5, Overall 3.977e-6 https://gnomad.broadinstitute.org/variant/14-23887429-C-T

    5. CasePT-62: United States

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: HP:0001650, HP:0001658 (Aortic valve stenosis, Myocardial infarction)

      NotHPOsFreeText: N/A

      CaseAddInfo:


      CaseGenotypingMethod: DNA was collected from the participants using blood samples. 18 genes suspected on contributing to HCM were targeted and sequenced. The variants were then located and filtered for pathogenicity.


      Variant: NM_000257.3:c.1370T>C (p.Ile457Thr)

      ClinVar: 42840 https://www.ncbi.nlm.nih.gov/clinvar/variation/42840/

      gnomAD: European (Non-Finnish) 8.790e-6, Overall 3.976e-6 https://gnomad.broadinstitute.org/variant/14-23898201-A-G

    1. Supplementary Data: Online Table 2a

      Case:

      CasePreviousTesting: Full sarcomere testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), Additional testing (ABCC9, ACTN2, ANKRD1, BAG3, CALR3, CRYAB, CSRP3, DES, DMD, DSC2, DSG2, DSP, EMD, GLA, JPH2, JUP, LAMA4, LAMP2, LMNA, MYH6, MYPN, MYOZ1, MYOZ2, PKP2, PLN, PRKAG2, RBM20, RYR2, SCN5A, SGCD, TAZ, TCAP, TMEM43, TNNC1, TTN, VCL and LDB3)

      CaseGenotypingMethod: DNA isolated from peripheral blood, targeted enrichment, next-gen sequencing with panel of 46 genes

      Variant: NM_000257.3:c.5773C>G

      CAID: CA257807342, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA257807342

      gnomAD: n/a

    2. Supplementary Data: Online Table 3

      Case:

      CasePreviousTesting: Full sarcomere testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), Additional testing (ABCC9, ACTN2, ANKRD1, BAG3, CALR3, CRYAB, CSRP3, DES, DMD, DSC2, DSG2, DSP, EMD, GLA, JPH2, JUP, LAMA4, LAMP2, LMNA, MYH6, MYPN, MYOZ1, MYOZ2, PKP2, PLN, PRKAG2, RBM20, RYR2, SCN5A, SGCD, TAZ, TCAP, TMEM43, TNNC1, TTN, VCL and LDB3)

      CaseGenotypingMethod: DNA isolated from peripheral blood, targeted enrichment, next-gen sequencing with panel of 46 genes

      Variant: NM_000257.3:c.4048_4050del

      CAID: CA913184874, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA913184874

      gnomAD: n/a

    3. Supplementary Data: Online Table 2a

      Case:

      CasePreviousTesting: Full sarcomere testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), Additional testing (ABCC9, ACTN2, ANKRD1, BAG3, CALR3, CRYAB, CSRP3, DES, DMD, DSC2, DSG2, DSP, EMD, GLA, JPH2, JUP, LAMA4, LAMP2, LMNA, MYH6, MYPN, MYOZ1, MYOZ2, PKP2, PLN, PRKAG2, RBM20, RYR2, SCN5A, SGCD, TAZ, TCAP, TMEM43, TNNC1, TTN, VCL and LDB3)

      CaseGenotypingMethod: DNA isolated from peripheral blood, targeted enrichment, next-gen sequencing with panel of 46 genes

      Variant: NM_000257.3:c.2085_2097dup

      CAID: CA704294509, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000257.3%3Ac.2085_2097dup

      gnomAD: n/a

    4. Supplementary Data: Online Table 3

      Case:

      CasePreviousTesting: Full sarcomere testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), Additional testing (ABCC9, ACTN2, ANKRD1, BAG3, CALR3, CRYAB, CSRP3, DES, DMD, DSC2, DSG2, DSP, EMD, GLA, JPH2, JUP, LAMA4, LAMP2, LMNA, MYH6, MYPN, MYOZ1, MYOZ2, PKP2, PLN, PRKAG2, RBM20, RYR2, SCN5A, SGCD, TAZ, TCAP, TMEM43, TNNC1, TTN, VCL and LDB3)

      CaseGenotypingMethod: DNA isolated from peripheral blood, targeted enrichment, next-gen sequencing with panel of 46 genes

      Variant: NM_000257.3(MYH7):c.5534G>A (p.Arg1845Gln)

      ClinVar: 181286, https://www.ncbi.nlm.nih.gov/clinvar/variation/181286/

      gnomAD: 0.000004023, https://gnomad.broadinstitute.org/variant/14-23884229-C-T

    5. Supplementary Data: Online Table 2a

      Case:

      CasePreviousTesting: Full sarcomere testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), Additional testing (ABCC9, ACTN2, ANKRD1, BAG3, CALR3, CRYAB, CSRP3, DES, DMD, DSC2, DSG2, DSP, EMD, GLA, JPH2, JUP, LAMA4, LAMP2, LMNA, MYH6, MYPN, MYOZ1, MYOZ2, PKP2, PLN, PRKAG2, RBM20, RYR2, SCN5A, SGCD, TAZ, TCAP, TMEM43, TNNC1, TTN, VCL and LDB3)

      CaseGenotypingMethod: DNA isolated from peripheral blood, targeted enrichment, next-gen sequencing with panel of 46 genes

      Variant: NM_000257.3:c.902T>A

      CAID: CA389051788, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA389051788

      gnomAD: n/a

    6. Supplementary Data: Online Table 1a

      Case:

      CasePreviousTesting: Full sarcomere testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), Additional testing (ABCC9, ACTN2, ANKRD1, BAG3, CALR3, CRYAB, CSRP3, DES, DMD, DSC2, DSG2, DSP, EMD, GLA, JPH2, JUP, LAMA4, LAMP2, LMNA, MYH6, MYPN, MYOZ1, MYOZ2, PKP2, PLN, PRKAG2, RBM20, RYR2, SCN5A, SGCD, TAZ, TCAP, TMEM43, TNNC1, TTN, VCL and LDB3)

      CaseGenotypingMethod: DNA isolated from peripheral blood, targeted enrichment, next-gen sequencing with panel of 46 genes

      Variant: NM_000257.3(MYH7):c.732+1G>A

      ClinVar: 14127, https://www.ncbi.nlm.nih.gov/clinvar/variation/14127/

      gnomAD: 0.000003976, https://gnomad.broadinstitute.org/variant/14-23900793-C-T

    1. Family B, II:1

      CaseBII-1: Male, 23 years diagnosis, China, Asian

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: No family history, pedigree provided

      CasePresentingHPOs: HP:0001639, HP:0100749 (Hypertrophic cardiomyopathy, Chest pain)

      HPOsFreeText: Interventricular septal thickness at 15.6 mm, Left ventricular posterior wall thickness at 12.1 mm

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: Parents tested negative for variant, therefore it is asserted as de novo

      CasePreviousTesting: See list of sequenced genes

      CaseGenotypingMethod: Genomic DNA was isolated from whole blood of all patients and controls. Whole coding exons and exon-intron boundaries of the 19 HCM-related genes listed above were amplified and sequenced on Ion Torrent PGM. These variants were then filtered for pathogenicity and compared to the controls. Any mutations found were confirmed by conventional dideoxy sequencing and Sanger sequencing.

      Variant: NM_000257.3:c.2572C>T (p.Arg858Cys)

      ClinVar: 164324 https://www.ncbi.nlm.nih.gov/clinvar/variation/164324/

      gnomAD: Not in gnomAD

    2. A14

      CaseA14: Female, 44 years report, China, Asian

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: No family history

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: Interventricular septal thickness at 17.6 mm, Left ventricular posterior wall thickness at 8.8 mm, Left ventricular end-diastolic diameter at 42.7 mm, Left ventricular septal thickness at 36.6 mm, Left ventricular ejection fraction at 68%

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: See list of sequenced genes

      CaseGenotypingMethod: Genomic DNA was isolated from whole blood of all patients and controls. Whole coding exons and exon-intron boundaries of the 19 HCM-related genes listed above were amplified and sequenced on Ion Torrent PGM. These variants were then filtered for pathogenicity and compared to the controls. Any mutations found were confirmed by conventional dideoxy sequencing and Sanger sequencing.

      Variant: NM_000257.3:c.161G>A (p.Arg54Gln)

      ClinVar: 42856 https://www.ncbi.nlm.nih.gov/clinvar/variation/42856/

      gnomAD: East Asian 2.506e-4, Overall 2.475e-5 https://gnomad.broadinstitute.org/variant/14-23902781-C-T

    1. AJV

      CaseAJV: 17 years diagnosis, Australia

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: Father (index case) died awaiting cardiac transplant (carried both variants). Two possibly affected relatives.

      CasePresentingHPOs: HP:0001639, HP:0006536

      (Hypertrophic cardiomyopathy, Obstructive lung disease)

      HPOsFreeText: Maximum left ventricular hypertrophy at 17 mm, Sudden cardiac death event at 17 years, Maximal wall thickness at 22mm,

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CasePreviousTesting: See Table 1

      CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.

      Variant:NM_000257.3:c.1954A>G (p.Arg652Gly)

      ClinVarID:177626 https://www.ncbi.nlm.nih.gov/clinvar/variation/177626/

      gnomAD: Not in gnomAD

      Multiple Gene Variants:

      MYBPC3 Variant

      Variant: NM_000256.3:c.2980C>T (p.Leu994Phe)

      ClinVarID:180992 https://www.ncbi.nlm.nih.gov/clinvar/variation/180992/

      gnomAD: European (Non-Finnish) 1.624e-4, Overall 8.461e-5 https://gnomad.broadinstitute.org/variant/11-47355487-G-A

    1. 2. Case report

      CaseIII/2: 70 year old Caucasian female

      DiseaseAssertion: spinal muscular atrophy (SMA),

      FamilyInfo: family history was indicative of an autosomal dominant neuromuscular disorder in at least five generations

      CasePresentingHPOs: HP:0002076, HP:0003393, HP:0007149, HP:0000365

      "Migraine, Thenar muscle atrophy, Distal upper limb amyotrophy, Hearing impairment"

      CaseHPOFreeText: impaired mobility of the thumb at age 49 y followed by weakness of the other fingers, mild foot drop bilaterally, recurrent, spontaneous, short-lived aching of the shoulder girdle muscles, reduced tendon reflexes on the upper limbs, weak head anteflexion, recurrent anginal chest pain, reduced Achilles tendon reflexes, and diffuse wasting of all limbs

      GenotypingMethod: "DNA analysis"

      Variant: NM_000257.4:c.5566G>A

      ClinVar: 190403

      CAID: CA347253

      gnomAD: https://gnomad.broadinstitute.org/variant/14-23883305-C-T

      0.000008795 European (non-Finnish)

    1. Supplementary Data table 1

      Case:

      DiseaseAssertion: hypertrophic cardiomyopathy

      CaseHPOFreeText: maximal wall thickness (MWT) ≥15 mm

      CasePreviousTesting: Full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), Additional testing (TNNC1, CSRP3, TCAP, ABCC9, ACTN2, ANKRD1, BAG3, CALR3, CAV3, CRYAB, CTNNA3, DES, DSC2, DSG2, DSP, EMD, FHL1, GLA, JPH2, JUP, LAMA4, LAMP2, LDB3, LMNA, MIB1, MYH6, MYOZ2, MYPN, NEXN, PKP2, PLN, PRDM16, PRKAG2, RBM20, SCN5A, TAZ, TMEM43, TNNC1, TTN, TTR, VCL), electrocardiography

      CaseGenotypingMethod: direct sequencing of all coding intron-exon boundaries of 12 genes (prior to 2012), next-generation sequencing (post 2012)

      Variant: NM_000257.3:c.3100-2A>C

      CAID: CA035633, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA035633

      gnomAD: 0.00002475, https://gnomad.broadinstitute.org/variant/14-23891536-T-G

    2. Supplementary Data table 1

      Case:

      DiseaseAssertion: hypertrophic cardiomyopathy

      CaseHPOFreeText: maximal wall thickness (MWT) ≥15 mm

      CasePreviousTesting: Full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), Additional testing (TNNC1, CSRP3, TCAP, ABCC9, ACTN2, ANKRD1, BAG3, CALR3, CAV3, CRYAB, CTNNA3, DES, DSC2, DSG2, DSP, EMD, FHL1, GLA, JPH2, JUP, LAMA4, LAMP2, LDB3, LMNA, MIB1, MYH6, MYOZ2, MYPN, NEXN, PKP2, PLN, PRDM16, PRKAG2, RBM20, SCN5A, TAZ, TMEM43, TNNC1, TTN, TTR, VCL), electrocardiography

      CaseGenotypingMethod: direct sequencing of all coding intron-exon boundaries of 12 genes (prior to 2012), next-generation sequencing (post 2012)

      Variant: NM_000257.3(MYH7):c.2945T>C (p.Met982Thr)

      ClinVar: 42941, https://www.ncbi.nlm.nih.gov/clinvar/variation/42941/

      gnomAD: 0.0008484, https://gnomad.broadinstitute.org/variant/14-23892910-A-G

    1. Supplementary Data: Table S3

      Case 35:

      DiseaseAssertion: left ventricular noncompaction

      CasePresentingHPOs: HP:0030682 (left ventricular noncompaction)

      CaseHPOFreeText: >7yo, able to hold breath, non compacted segment = distinct 2-layered appearance of trabeculated and compacted myocardium, NC/C ratio > 2.3:1

      CasePreviousTesting: Cardiac MRI using 17-segment model of LV segmentation, ECG, transthoracic echocardiography, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplementary data tables S1 and S2.

      CaseGenotypingMethod: WES, variant enrichment analysis

      Variant: NM_000257.3(MYH7):c.115G>A (p.Val39Met)

      ClinVar: 42827, https://www.ncbi.nlm.nih.gov/clinvar/variation/42827/

      gnomAD: 0.00004596, https://gnomad.broadinstitute.org/variant/14-23902827-C-T

    2. Supplementary Data: Table S3

      Case 90:

      DiseaseAssertion: left ventricular noncompaction

      CasePresentingHPOs: HP:0030682 (left ventricular noncompaction)

      CaseHPOFreeText: >7yo, able to hold breath, non compacted segment = distinct 2-layered appearance of trabeculated and compacted myocardium, NC/C ratio > 2.3:1

      CasePreviousTesting: Cardiac MRI using 17-segment model of LV segmentation, ECG, transthoracic echocardiography, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplementary data tables S1 and S2.

      CaseGenotypingMethod: WES, variant enrichment analysis

      Variant: NM_000257.3(MYH7):c.745C>T (p.Arg249Ter)

      ClinVar: 407183, https://www.ncbi.nlm.nih.gov/clinvar/variation/407183/

      gnomAD: 0.000003977, https://gnomad.broadinstitute.org/variant/14-23900678-G-A

      MultipleGeneVariants:

      (1) TPM1 Variant:

      Variant: NM_001018004.1(TPM1):c.775A>G (p.Lys259Glu)

      ClinVar: 43687, https://www.ncbi.nlm.nih.gov/clinvar/variation/43687/

      gnomAD: 0.0008382, https://gnomad.broadinstitute.org/variant/15-63363291-A-G

      (2) PRKAG2 Variant:

      Variant: p.Lys133Ile no ClinVar or CAID

    3. Supplementary Data: Table S3

      Case 12:

      DiseaseAssertion: left ventricular noncompaction

      CasePresentingHPOs: HP:0030682 (left ventricular noncompaction)

      CaseHPOFreeText: >7yo, able to hold breath, non compacted segment = distinct 2-layered appearance of trabeculated and compacted myocardium, NC/C ratio > 2.3:1

      CasePreviousTesting: Cardiac MRI using 17-segment model of LV segmentation, ECG, transthoracic echocardiography, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplementary data tables S1 and S2.

      CaseGenotypingMethod: WES, variant enrichment analysis

      Variant: NM_000257.3(MYH7):c.5786C>T (p.Thr1929Met)

      ClinVar: 181397, https://www.ncbi.nlm.nih.gov/clinvar/variation/181397/

      gnomAD: 0.00005308, https://gnomad.broadinstitute.org/variant/14-23882972-G-A

    1. CaseST4-91: Sweden

      DiseaseAssertion: Idiopathic Dilated Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001644 (Dilated cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: HP:0002140, HP:0000822, HP:0001654, HP:0030955, HP:0000819, HP:0002666, HP:0000845, HP:0000820 (Ischemic stroke, Hypertension, Valvular heart disease, Alcoholism, Diabetes mellitus, Pheochromocytoma, Acromegaly, Thyroid disease)

      NotHPOsFreeText: Patients were excluded for significant systemic infection, systemic diseases, previous cancer treatment including irradiation, and tachycardia-induced cardiomyopathy or other primary cardiomyopathy.

      CaseAddInfo: N/A

      CasePreviousTesting: See Supplemental Table 1

      CaseGenotypingMethod: Genomic DNA was extracted from the patients. 41 exons of previously-reported genes that were reported in DCM patients were amplified and directly sequenced. Afterwards, the variants were aligned and sorted for pathogenicity.

      Variant: NM_000257.3:c.1113G>C (p.Glu371Asp)

      CAID: CA389051328 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000257.3%3Ac.1113G%3EC

      gnomAD: Not in gnomAD

    1. CLINICAL REPORT

      Case1: male fetus

      DiseaseAssertion: LVNC

      FamilyInfo: first two pregnancies had resulted in miscarriages due to cervical insufficiency. The third pregnancy (after cerclage) resulted in a healthy nondysmorphic female with mild Ebstein anomaly of the tricuspid valve. The father was reported to have a history of a cardiac murmur and possible “hole in the heart.” Fetal echocardiography revealed that our patient's second child (fourth pregnancy) also had mild Ebstein anomaly. Father also has Ebstein anomaly, with significant apical displacement of the tricuspid valve, moderate tricuspid valve insufficiency, and right heart enlargement

      CasePresentingHPOs: HP:0010316, HP:0031195

      "Ebstein anomaly of the tricuspid valve, Apical hypertrabeculation of the left ventricle"

      CaseHPOFreeText: mild apical displacement of the tricuspid valve, presence of multiple trabeculations on parasternal short‐axis and apical 4‐chamber views, with deep intertrabecular recesses

      CaseNotHPOs:

      CaseNotHPOFreeText:

      CasePreviousTesting: echocardiogram, Peripheral blood samples use to test 46 genes initially (including MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1)

      GenotypingMethod: Testing was performed by oligonucleotide‐based target capture, followed by next generation sequencing. Sanger sequencing was used to provide data in areas with insufficient coverage and confirm clinically significant and novel variants. Heterozygous.

      VariantMYH7: NM_000257.4:c.3658_3660del

      ClinVar: 42968

      CAID: CA013921

      gnomAD: not reported

      **VariantTTN: c.25722_25724delAGA (p.Glu8576del)

      Allele registry currently not working

    1. Supplementary Material 4

      Case M-14: Japanese

      DiseaseAssertion: idiopathic cardiomyopathy (HCM and DCM)

      CasePreviousTesting: Clinical evaluation, chest radiography, electrocardiography, echocardiography, cardiac catheterization, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1)

      CaseGenotypingMethod: 8 sarcomeric genes amplified from genomic DNA via PCR then screened using bidirectional direct sequencing

      Variant: NM_000257.3(MYH7):c.2155C>T (p.Arg719Trp)

      ClinVar: 14104, https://www.ncbi.nlm.nih.gov/clinvar/variation/14104/

      gnomAD: 0.00003185, https://gnomad.broadinstitute.org/variant/14-23895180-G-A

    2. Supplementary Material 4

      Case M-22: Japanese

      DiseaseAssertion: idiopathic cardiomyopathy (HCM and DCM)

      CasePreviousTesting: Clinical evaluation, chest radiography, electrocardiography, echocardiography, cardiac catheterization, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1)

      CaseGenotypingMethod: 8 sarcomeric genes amplified from genomic DNA via PCR then screened using bidirectional direct sequencing

      Variant: NM_000257.3(MYH7):c.2333A>G (p.Asp778Gly)

      ClinVar: 14100, https://www.ncbi.nlm.nih.gov/clinvar/variation/14100/

      gnomAD: n/a

    3. Supplementary Material 4

      Case M-15: Japanese

      DiseaseAssertion: idiopathic cardiomyopathy (HCM and DCM)

      CasePreviousTesting: Clinical evaluation, chest radiography, electrocardiography, echocardiography, cardiac catheterization, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1)

      CaseGenotypingMethod: 8 sarcomeric genes amplified from genomic DNA via PCR then screened using bidirectional direct sequencing

      Variant: NM_000257.3(MYH7):c.2155C>T (p.Arg719Trp)

      ClinVar: 14104, https://www.ncbi.nlm.nih.gov/clinvar/variation/14104/

      gnomAD: 0.00003185, https://gnomad.broadinstitute.org/variant/14-23895180-G-A

    1. 9

      Case: Case 9, male, 69yo

      CasePresentingHPOs: HP:0031318 (myocardial fiber disarray)

      HPOsFreeText: BMI = 25.2kg/m^2, cause of death: accidental head injury, heart weight = 624g, left ventricular thickness = 1.8cm, distribution of myocyte disarray in ventricular septum, area of disarray = 7.8%, grade of fibrosis = 3

      CaseNotHPOs: HP:0031296 (atrial septal hypertrophy)

      CasePreviousTesting: NGS of 81 cardiovascular disorder-related genes (Supplemental Table S1)

      CaseGenotypingMethod: genomic DNA extracted from whole blood, PCR, NGS of 81 cardiovascular disorder-related genes (Supplemental Table S1)

      Variant: NM_000257.4(MYH7):c.2822G>A (p.Arg941His)

      ClinVar: 636633, https://www.ncbi.nlm.nih.gov/clinvar/variation/636633/

      gnomAD: 0.00001590, https://gnomad.broadinstitute.org/variant/14-23893216-C-T?dataset=gnomad_r2_1

    1. N3

      Case N3: Tunisia, Female, 28yo at onset, 30yo at study

      DiseaseAssertion: hypertrophic cardiomyopathy

      CasePresentingHPOs: HP:0100749 (chest pain)

      CaseHPOFreeText: left ventricular septum (LVS) ≥15 mm, septum size = 25mm

      FamilyInfo: Family history of HCM and sudden cardiac death

      CasePreviousTesting: Full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), Additional testing (FLNC, TNNC1), electrocardiogram, echocardiography

      CaseGenotypingMethod: PCR, Next-generation sequencing, identified variants confirmed via Sanger Sequencing

      Variant: NM_000257.3:c.5639G>A

      CAID: CA257807907, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA257807907

      gnomAD: n/a

      MultipleGeneVariants:

      (1) MYBPC3 Variant:

      Variant: NM_000256.3(MYBPC3):c.772G>A (p.Glu258Lys)

      ClinVar: 42792, https://www.ncbi.nlm.nih.gov/clinvar/variation/42792/

      gnomAD: 0.00001656, https://gnomad.broadinstitute.org/variant/11-47369975-C-T

    2. N39

      Case N39: Tunisia, Male, 30yo at onset, 40yo at study

      DiseaseAssertion: hypertrophic cardiomyopathy

      CasePresentingHPOs: HP:0100749, HP:0002094 (chest pain, dyspnea)

      CaseHPOFreeText: left ventricular septum (LVS) ≥15 mm, septum size = 26mm

      FamilyInfo: no family history of HCM or sudden cardiac death

      CasePreviousTesting: Full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), Additional testing (FLNC, TNNC1), electrocardiogram, echocardiography

      CaseGenotypingMethod: PCR, Next-generation sequencing, identified variants confirmed via Sanger Sequencing

      Variant: NM_000257.3:c.353C>T

      CAID: CA389052998, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA389052998

      gnomAD: n/a

      MultipleGeneVariants:

      (1) MYBPC3 Variant:

      Variant: NM_000256.3:c.3296G>A

      CAID: CA380314113, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA380314113

      gnomAD: 0.000004667, https://gnomad.broadinstitute.org/variant/11-47354779-C-T

    1. II-9

      Case#: II-9, female, 46 yrs

      DiseaseAssertion: HCM

      FamilyInfo: Yes, 2 siblings and niece have HCM

      CasePresentingHPOs: chest tightness, palpitations (HP:0031352, HP:0001962)

      CaseHPOFreeText: T flattened and inverted and left axis deviation (-48 degrees), 22mm MLVWT, 63% LVE F, 1.29 E/A ratio, LVOT-PG 4mm

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      CaseGenotypingMethod: sequencing, physical examination, ECG, 3D modeling, statistical analysis

      MultipleGeneVariants:

      (1) Variant: absent (MYH7- A934V)

      ClinVar: N/A

      CAID: CA389047003

      gnomAD: absent

      (2) Variant: NM_000257.4(MYH7):c.4159G>A (p.Glu1387Lys)

      ClinVar: 181244 https://www.ncbi.nlm.nih.gov/clinvar/variation/181244/

      CAID: N/A

      gnomAD: 0.00003266 South Asian https://gnomad.broadinstitute.org/variant/14-23887429-C-T

    1. CaseMYH7-7: Japan, Asian

      CasePresentingHPOs: HP:0001639, HP:0006685 (Hypertrophic cardiomyopathy, Endomyocardial fibrosis)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo:


      CaseGenotypingMethod: Genomic DNA was extracted from whole blood from each proband. They each had 95 genes associated with DCM, HCM, and other inherited cardiovascular diseases sequenced with a panel, including both the exons and spicing regions. Variants were then filtered for rarity and pathogenicity.


      Variant: NM_000257.3:c.1358G>A (p.Arg453His)

      ClinVar: 42838 https://www.ncbi.nlm.nih.gov/clinvar/variation/42838/

      gnomAD: Not in gnomAD

    2. CaseMYH7-9: Japan, Asian

      CasePresentingHPOs: HP:0001639, HP:0006685 (Hypertrophic cardiomyopathy, Endomyocardial fibrosis)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo:


      CaseGenotypingMethod: Genomic DNA was extracted from whole blood from each proband. They each had 95 genes associated with DCM, HCM, and other inherited cardiovascular diseases sequenced with a panel, including both the exons and spicing regions. Variants were then filtered for rarity and pathogenicity.


      Variant: NM_000257.3:c.1012G>A (p.Val338Met)

      ClinVar: 164381 https://www.ncbi.nlm.nih.gov/clinvar/variation/164381/

      gnomAD: Not in gnomAD

    1. Supplementary Data, Table 2

      Case: Australian

      DiseaseAssertion: HCM

      CaseHPOFreeText: maximum left ventricular wall thickness of ≥15 mm

      CasePreviousTesting: electrocardiography, echocardiography, Full testing (MYBPC3, MYH7, TNNT2, TNNI3, TPM1, MYL2, MYL3, ACTC1)

      CaseGenotypingMethod: DNA isolated from peripheral blood or buccal swabs, PCR, Sanger sequencing, segregation analysis, haplotype analysis of MYBPC3 and MYH7

      Variant: NM_000257.3(MYH7):c.1727A>G (p.His576Arg)

      ClinVar: 177625, https://www.ncbi.nlm.nih.gov/clinvar/variation/177625/

      gnomAD: 0.00001768, https://gnomad.broadinstitute.org/variant/14-23896955-T-C

    2. Supplementary Data, Table 2

      Case: Australian

      DiseaseAssertion: HCM

      CaseHPOFreeText: maximum left ventricular wall thickness of ≥15 mm

      CasePreviousTesting: electrocardiography, echocardiography, Full testing (MYBPC3, MYH7, TNNT2, TNNI3, TPM1, MYL2, MYL3, ACTC1)

      CaseGenotypingMethod: DNA isolated from peripheral blood or buccal swabs, PCR, Sanger sequencing, segregation analysis, haplotype analysis of MYBPC3 and MYH7

      Variant: NM_000257.3(MYH7):c.2155C>T (p.Arg719Trp)

      ClinVar: 14104, https://www.ncbi.nlm.nih.gov/clinvar/variation/14104/

      gnomAD: 0.00003185, https://gnomad.broadinstitute.org/variant/14-23895180-G-A

    1. Case 1 (II2):

      CaseII2: 65 year old male

      DiseaseAssertion: left ventricular non compaction cardiomyopathy

      FamilyInfo: three family members presenting with the same MYH7 mutation

      CasePresentingHPOs: HP:0012764, HP:0002515, HP:0003376, HP:0003307, HP:0003391, HP:0003547

      "Orthopnea, Waddling gait, Steppage gait, Hyperlordosis, Gowers sign, Shoulder girdle muscle weakness"

      CaseHPOFreeText: shortness of breath during exertion, foot drop, At lower limbs weakness and hypotrophy were severe in distal muscles and moderate in proximal muscles

      CaseNotHPOs:

      CaseNotHPOFreeText:

      CasePreviousTesting: molecular analysis for ACTA1 and ITGA7 was performed, resulted negative. Molecular analysis for DES, LMNA and MYH7 genes were carried out

      GenotypingMethod: mutation screening, primers flanking the intron-exon junctions of each MYH7 exon, the 5′ and 3′ UTR

      Variant: NM_000257.4:c.5401G>A

      ClinVar: 43069

      CAID: CA016087

      gnomAD: not found

    1. proband’s sister (Fig 1, II.2)

      Case II-2: Italian, Female

      DiseaseAssertion: severe obstructive hypertrophic cardiomyopathy

      CasePresentingHPOs:

      CaseHPOFreeText: interventricular septal and/or posterior wall thickness in end-diastole ≥15 mm, had surgical myectomy

      CasePreviousTesting: M-mode-2D and color-Doppler study to analyze cardiac chamber dimensions, global systolic and diastolic function, valve and great arteries anomalies, echocardiography,

      CaseGenotypingMethod: exon 23 and flanking regionals analyzed via Sanger Sequencing, Variants found via exome sequencing tested for segregation in family by Sanger sequencing on an ABI PRISM 3130 DNA sequencer

      Variant: NM_000257.3:c.2795T>A

      CAID: CA389047028, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA389047028

      gnomAD: n/a

    1. IV-6

      Case IV-6: Female, Iranian, 34yo at diagnosis, 37yo at study

      DiseaseAssertion: DCM (initially); paper notes that phenotype is more consisted with hypokinetic non-dilated cardiomyopathy based on guideline from ESC working group on myocardial and pericardial diseases (PMID: 26792875)

      FamilyInfo: consanguineous family, pedigree in fig. 1

      CasePresentingHPOs: HP:0001653, HP:0002375 (mitral regurgitation, hypokinesia)

      CaseHPOFreeText: New York Heart Association Class = II, left ventricular ejection fraction = 35%, left ventricular internal end-diastolic diameter = 5.2cm, left ventricular internal end-systolic diameter = 4.2cm, interventricular septum = 0.9cm, posterior wall = 1.0cm, normal sinus rhythm, grade I diastolic function

      CaseNotHPOFreeText:

      CasePreviousTesting: ECG, Full testing (https://hyp.is/2c24ajtuEemXQ-fRmGkjTA/www.sciencedirect.com/science/article/pii/S1769721217300484)

      CaseGenotypingMethod: https://hyp.is/IKjfsDtxEem3Sh8RHHdYSg/www.sciencedirect.com/science/article/pii/S1769721217300484) WES, targeted exome sequence capture using SureSelectXT Human All Excon v5 kig (Agilent), co-segregation analysis via Sanger sequencing

      Variant: NM_000257.3(MYH7):c.2863G>A (p.Asp955Asn)

      ClinVar: 264608, https://www.ncbi.nlm.nih.gov/clinvar/variation/264608/

      gnomAD: 0.000003976, https://gnomad.broadinstitute.org/variant/14-23893175-C-T

      MultipleGeneVariants:

      (1) TNNT2 Variant:

      Variant: NM_000364.3(TNNT2):c.247A>C (p.Asn83His)

      ClinVar: 427814, https://www.ncbi.nlm.nih.gov/clinvar/variation/427814/

      gnomAD: n/a

    1. KMP 11

      Case KMP 11: Eastern Slovakia, Female, 57yo

      DiseaseAssertion: hypertrophic cardiomyopathy

      FamilyInfo: positive family history

      CaseHPOFreeText: left ventricular ejection fraction = 60%, New York Heart Association Classification I

      CaseNotHPOFreeText: left ventricular outflow tract obstruction

      CasePreviousTesting: 12-lead ECG, echocardiography, partial testing (MYBPC3, MYH7, NEBL, SCN5A, TNNI3, TNNT2)

      CaseGenotypingMethod: genomic DNA collected from peripheral blood leukocytes, Sanger sequencing

      Variant: NM_000257.3(MYH7):c.2845G>A (p.Glu949Lys)

      ClinVar: 14093, https://www.ncbi.nlm.nih.gov/clinvar/variation/14093/

      gnomAD: n/a

    1. Clinical features of patient V-4

      CaseV-4: Female, 11 years old

      DiseaseAssertion: CFTD and LVNC

      FamilyInfo: Multigenerational Italian family. Phenotypic data were available for 10 individuals (3 males and 7 females) ranging in age from 4 to 50 years old. All individuals were of Caucasian ancestry. DNA was available for 6 individuals (IV-10, IV-13, IV-14, V-1, V-4, V-5). Authors identified a mild LVNC phenotype in the mother (IV-14), sister (V-5) and cousin (V-1) of the proband, with hypertabeculations of the mid inferolateral wall and of the ape and without neuromuscular disorders. During the growth, there was a reduction of clinical signs in patients V-1 and V-5. No data have been collected for individual IV-9, who died at the age of 35 of unknown causes. The father (IV-13) of the proband was asymptomatic.

      Proband is the first child of a family with a history of consanguinity (mother’s parents are first-degree cousins) and diabetes in the maternal line (grandmother, one great-uncle, one uncle and a first-degree cousin) without neuromuscular diseases.

      LVNC segregated as a dominant mode of inheritance with high phenotypic heterogeneity and reduced penetrance. CFTD phenotype showed a recessive mode of inheritance.

      CasePresentingHPOs: HP:0001290, HP:0002033, HP:0001643, HP:0001655, HP:0001374, HP:0004325, HP:0001943, HP:0001508, HP:0002515, HP:0002650, HP:0001284

      "Generalized hypotonia, poor suck, Patent ductus arteriosus, Patent foramen ovale, Congenital hip dislocation, Decreased body weight (below 3rd percentile), Hypoglycemia, Failure to thrive, waddling gait, Scoliosis, Areflexia

      CaseHPOFreeText: persistent crying, Persistent arterial duct and patent foramen ovale were diagnosed at birth but resolved spontaneously, as shown by echocardiography at the age of 1 month, congenital dislocation of the left hip, at 17 months of age hospitalized due to body weight below the third percentile and hypoglycemia, difficulties in chewing and swallowing, inability to stand up from a sitting position, a slight degree of weakness of the facial and masticator muscles, mild weakness of the glutei and ileo-psoas and marked bilateral quadriceps, Tendon reflexes were absent. Joints contractures had never been observed, A blood test confirmed hypoglycemia and normal levels of serum creatine kinase and isoenzymes, quadriceps muscle biopsy displayed a predominance of type 1 fibers

      CaseNotHPOs:

      CaseNotHPOFreeText: internal nuclei, nemaline bodies, cores were observed

      CasePreviousTesting: Authors extended the clinical and instrumental (EMG, ECG, Echocardiography, muscle biopsy) evaluation to the whole family, Echocardiography showed a slight left ventricular (LV) dilatation, a moderate reduction of the LV global function (ejection fraction 40%), and a non-compacted aspect of the overall infero-lateral wall. The karyotype and FISH were normal. The serum creatine kinase (CK) was within the normal range, Dystrophin, emerin, calpain and lamin A/C were examined and found to be normal, cardiological investigation confirmed a long QTc and showed signs of left ventricular hypertrophy and repolarization abnormalities in the ECG, performed a thorough survey of all previously identified CFTD and LVNC genes to definitively exclude their involvement in the disease phenotype. Only intronic polymorphic variants were detected in TPM3, ACTA1, TPM2, MYL2, MYL3, G4.5, DTNA, ZASP, ACTC1, MYBPC3 and TMP1. Both intronic and coding polymorphic variants were detected in SEPN1, RYR1, MYH7, LMNA/C, TNNT2 and TNNI3

      GenotypingMethod: Whole-exome sequencing of the proband and her cousin

      VariantMYH7B: NM_020884.5:c.2668C>T

      ClinVar:

      CAID: CA9827409

      gnomAD: https://gnomad.broadinstitute.org/variant/20-33582046-C-T

    1. 18-year-old man

      Case1: 18 year old male

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: parents and 2 siblings all phenotype negative for HCM, tested negative for the mutation

      CasePresentingHPOs: HP:0001639, HP:0031992, HP:0031972, HP:0004755, HP:0004756

      "Hypertrophic cardiomyopathy, Apical hypertrophic cardiomyopathy, presyncope, Supraventricular tachycardia, Ventricular tachycardia"

      CasePreviousTesting: Authors simply state "on genetic testing"

      Variant: NM_000257.4:c.1588A>G

      ClinVar: 520309

      CAID: CA028909

      gnomAD: https://gnomad.broadinstitute.org/variant/14-23897094-T-C?dataset=gnomad_r2_1

      Total Allele Frequency 0.000003980 South Asian 0.00003266

    1. II-2

      CaseII-2: 34 year old female

      DiseaseAssertion: Laing distal myopathy

      FamilyInfo: Hungarian Roma Family, mother and third affected daughter present with MYH7 mutation, all three daughters present symptoms of myopathy

      CasePresentingHPOs: HP:0002938, HP:0003722, HP:0001284, HP:0009027, HP:0003376

      "Lumbar hyperlordosis, Neck flexor weakness, Areflexia, Foot dorsiflexor weakness, Steppage gait"

      CaseHPOFreeText: unable to walk unaided, generalized muscle atrophy involving the limbs and the paravertebral muscles, severe weakness of both proximal and distal muscles (especially in finger and toe extensors), deep tendon reflexes absent, foot drop, wheel-chair bound by age 27,

      CaseNotHPOs: n/a

      CaseNotHPOFreeText: respiratory or cardiac involvement

      CasePreviousTesting: n/a

      GenotypingMethod: WES and Sanger sequencing, trio exome sequencing approach including the two affected daughters (III-1 and III-2) and their unaffected father (II-1)

      Variant: NM_000257.4:c.4849_4851del

      ClinVar: 190401

      CAID: CA015411

      gnomAD: not found

    1. CaseIP-2: Male, Taiwan, Birth diagnosis

      HPOsFreeText: 4MU enzyme activity at 0.43, MS/MS ennzyme activity at 0.13

      GenotypingMethod: GAA Gene Sequencing and PCR Amplification


      Variant in literature as c.1396C>T, however the reference has G there. Corrected for poossible typo.

      Variant1: NM_000152.4:c.1396G>T (p.Val466Phe)

      CAID: CA401366509 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.1396G%3ET

      gnomAD: Not in gnomAD


      Variant2: NM_000152.4:c.1935C>A (p.Asp645Glu)

      ClinVar: 4029 https://www.ncbi.nlm.nih.gov/clinvar/variation/4029/

      gnomAD: East Asian 1.729e-3, Overall 1.240e-4 http://gnomad.broadinstitute.org/variant/17-78086721-C-A


      CaseAddInfo: Infantile Onset Pompe Disease

    2. CaseOPOPD-63: Male, Taiwan, Birth diagnosis

      HPOsFreeText: GAA (MS/MS) enzyme activity at 1.05 umol/hr/L

      GenotypingMethod: GAA Gene Sequencing and PCR Amplification

      Variant1: NM_000152.4:c.1726G>A (p.Gly576Ser)

      ClinVar: 92467 https://www.ncbi.nlm.nih.gov/clinvar/variation/92467/

      gnomAD: East Asian 0.1427, Overall 0.01700 http://gnomad.broadinstitute.org/variant/17-78085871-G-A

      Variant2: NM_000152.4:c.2024_2026delACA (p.Asn675del)

      ClinVar: 189006 https://www.ncbi.nlm.nih.gov/clinvar/variation/189006/

      gnomAD: East Asian 1.106e-4, Overall 8.275e-6 http://gnomad.broadinstitute.org/variant/17-78086806-CACA-C

      CaseAddInfo: One Pompe Mutation allele and One Pseudodeficency Mutation allele, 3 other people have this genotype

    3. CaseLP2-2: Female, Taiwan, Birth diagnosis

      HPOsFreeText: GAA (MS/MS) enzyme activity at 0.08 umol/hr/L, Serum CK at 109 U/L

      GenotypingMethod: GAA Gene Sequencing and PCR Amplification


      Variant1: NM_000152.4:c.424_440del17 (p.Ser142Leufs*29)

      CAID: CA658795228 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.424_440del17

      gnomAD: Not in gnomAD


      Variant2: NM_000152.4:c.1958C>A (p.Thr653Asn)

      CAID: CA8815557 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.1958C%3EA

      gnomAD: East Asian 2.548e-4, Overall 1.825e-5 http://gnomad.broadinstitute.org/variant/17-78086744-C-A


      CaseAddInfo: Late Onset Pompe Disease

    4. CaseIP2-11: Male, Taiwan, Birth diagnosis

      HPOsFreeText: GAA (MS/MS) enzyme activity at 0.15 umol/hr/L, Serum CK at 662 U/L

      GenotypingMethod: GAA Gene Sequencing and PCR Amplification


      Variant1: NM_000152.4:c.1935C>A (p.Asp645Glu)

      ClinVar: 4029 https://www.ncbi.nlm.nih.gov/clinvar/variation/4029/

      gnomAD: East Asian 1.729e-3, Overall 1.240e-4 http://gnomad.broadinstitute.org/variant/17-78086721-C-A


      Variant2: NM_000152.4:c.1726G>A (p.Gly576Ser)

      ClinVar: 92467 https://www.ncbi.nlm.nih.gov/clinvar/variation/92467/

      gnomAD: East Asian 0.1427, Overall 0.01700 http://gnomad.broadinstitute.org/variant/17-78085871-G-A


      Variant3: NM_000152.4:c.2303C>T (p.Pro768Leu)

      CAID: CA401324900 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.2303C%3ET

      gnomAD: Not in gnomAD


      CaseAddInfo: Infantile Onset Pompe Disease, Nomenclature indicates that Variant 1 and 3 are in trans and that 2 is in cis with one of them

    5. CaseOPOPD-47: Male, Taiwan, Birth diagnosis

      HPOsFreeText: GAA (MS/MS) enzyme activity at 0.83 umol/hr/L

      GenotypingMethod: GAA Gene Sequencing and PCR Amplification


      Variant1: NM_000152.4:c.1461C>G (p.Phe487Leu)

      CAID: CA401366857 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.1461C%3EG

      gnomAD: Not in gnomAD


      Variant2: NM_000152.4:c.1726G>A (p.Gly576Ser)

      ClinVar: 92467 https://www.ncbi.nlm.nih.gov/clinvar/variation/92467/

      gnomAD: East Asian 0.1427, Overall 0.01700 http://gnomad.broadinstitute.org/variant/17-78085871-G-A


      CaseAddInfo: One Pompe Mutation allele and One Pseudodeficency Mutation allele

    6. CaseOPOPD-52: Female, Taiwan, Birth diagnosis

      HPOsFreeText: GAA (MS/MS) enzyme activity at 1.13 umol/hr/L

      GenotypingMethod: GAA Gene Sequencing and PCR Amplification


      Variant1: NM_000152.4:c.1726G>A (p.Gly576Ser)

      ClinVar: 92467 https://www.ncbi.nlm.nih.gov/clinvar/variation/92467/

      gnomAD: East Asian 0.1427, Overall 0.01700 http://gnomad.broadinstitute.org/variant/17-78085871-G-A


      Variant2: NM_000152.4:c.1850T>G (p.Val617Gly)

      CAID: CA401369628 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.1850T%3EG

      gnomAD: Not in gnomAD


      CaseAddInfo: One Pompe Mutation allele and One Pseudodeficency Mutation allele

    7. CaseOPOPD-72: Male, Taiwan, Birth diagnosis

      HPOsFreeText: GAA (MS/MS) enzyme activity at 1.31 umol/hr/L

      GenotypingMethod: GAA Gene Sequencing and PCR Amplification


      Variant1: NM_000152.4:c.1726G>A (p.Gly576Ser)

      ClinVar: 92467 https://www.ncbi.nlm.nih.gov/clinvar/variation/92467/

      gnomAD: East Asian 0.1427, Overall 0.01700 http://gnomad.broadinstitute.org/variant/17-78085871-G-A


      Variant2: NM_000152.4:c.2662G>T (p.Glu888Ter)

      ClinVar: 578595 https://www.ncbi.nlm.nih.gov/clinvar/variation/578595/

      gnomAD: East Asian 2.719e-4, Overall 1.998e-5 http://gnomad.broadinstitute.org/variant/17-78092467-G-T


      CaseAddInfo: One Pompe Mutation allele and One Pseudodeficency Mutation allele, 2 other patients have the same genotype

    8. CaseOPOPD-38: Female, Taiwan, Birth diagnosis

      HPOsFreeText: GAA (MS/MS) enzyme activity at 0.56 umol/hr/L

      GenotypingMethod: GAA Gene Sequencing and PCR Amplification


      Variant1: NM_000152.4:c.784G>A (p.Glu262Lys)

      ClinVar: 188806 https://www.ncbi.nlm.nih.gov/clinvar/variation/188806/

      gnomAD: East Asian 5.016e-5, Overall 1.417e-5 http://gnomad.broadinstitute.org/variant/17-78081447-G-A


      Variant2: NM_000152.4:c.1726G>A (p.Gly576Ser)

      ClinVar: 92467 https://www.ncbi.nlm.nih.gov/clinvar/variation/92467/

      gnomAD: East Asian 0.1427, Overall 0.01700 http://gnomad.broadinstitute.org/variant/17-78085871-G-A


      CaseAddInfo: One Pompe Mutation allele and One Pseudodeficency Mutation allele

    9. CaseOPTPD-1: Female, Taiwan, Birth diagnosis

      HPOsFreeText: GAA (MS/MS) enzyme activity at 1.47 umol/hr/L

      GenotypingMethod: GAA Gene Sequencing and PCR Amplification


      Variant1: NM_000152.4:c.1726G>A (p.Gly576Ser)

      ClinVar: 92467 https://www.ncbi.nlm.nih.gov/clinvar/variation/92467/

      gnomAD: East Asian 0.1427, Overall 0.01700 http://gnomad.broadinstitute.org/variant/17-78085871-G-A


      Variant2: NM_000152.4:c.546+5G>T

      ClinVar: 557811 https://www.ncbi.nlm.nih.gov/clinvar/variation/557811/

      gnomAD: East Asian 4.978e-4, Overall 3.824e-5 http://gnomad.broadinstitute.org/variant/17-78078936-G-T


      CaseAddInfo: One Pompe Mutation allele and Two Pseudodeficency Mutation alleles, Nomenclature indicates patient is homozygous for Variant 1 and Variant 2 is in cis with only one copy, 2 other patients have the same genotype

    10. CaseIP2-4: Female, Taiwan, Birth diagnosis

      HPOsFreeText: GAA (MS/MS) enzyme activity at 0.08 umol/hr/L, Serum CK at 385 U/L

      GenotypingMethod: GAA Gene Sequencing and PCR Amplification


      Variant1: NM_000152.4:c.1194+2T>C

      ClinVar: 370077 https://www.ncbi.nlm.nih.gov/clinvar/variation/370077/

      gnomAD: Not in gnomAD


      Variant2: NM_000152.4:c.1935C>A (p.Asp645Glu)

      ClinVar: 4029 https://www.ncbi.nlm.nih.gov/clinvar/variation/4029/

      gnomAD: East Asian 1.729e-3, Overall 1.240e-4 http://gnomad.broadinstitute.org/variant/17-78086721-C-A


      Variant3: NM_000152.4:c.1726G>A (p.Gly576Ser)

      ClinVar: 92467 https://www.ncbi.nlm.nih.gov/clinvar/variation/92467/

      gnomAD: East Asian 0.1427, Overall 0.01700 http://gnomad.broadinstitute.org/variant/17-78085871-G-A


      CaseAddInfo: Infantile Onset Pompe Disease, Nomenclature indicates Variant 1 and 2 are in trans, also that Variant 3 is in cis with only one of them

    11. CaseOPM-2: Male, Taiwan, Birth diagnosis

      HPOsFreeText: GAA (MS/MS) enzyme activity at 1.34 umol/hr/L

      GenotypingMethod: GAA Gene Sequencing and PCR Amplification


      Variant1: NM_000152.4:c.693-5C>T

      CAID: CA8814990 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.693-5C%3ET

      gnomAD: East Asian 3.516e-4, Overall 3.900e-5 http://gnomad.broadinstitute.org/variant/17-78081351-C-T


      Variant2: NM_000152.4:c.1726G>A (p.Gly576Ser)

      ClinVar: 92467 https://www.ncbi.nlm.nih.gov/clinvar/variation/92467/

      gnomAD: East Asian 0.1427, Overall 0.01700 http://gnomad.broadinstitute.org/variant/17-78085871-G-A


      CaseAddInfo: One Pompe Mutation, Nomenclature indicates Variants 1 and 2 are in cis and the other allele is Wildtype

    1. 10

      Case10: Male, 2.5 yr onset, 3 yr diagnosis, 13 yr report

      CasePresentingHPOs: HP:0001371 (Contractures)

      HPOsFreeText: FVC z-score sitting -3.01 (66% pred), FVC z-score supine -4.09 (54% pred), 84% MRC Scale, 1960 CK U/l, 8.6 GAA activity (nmol/h/mg)^h from cultured fibroblasts

      NotHPOsFreeText: No wheelchair used, No respiratory support

    1. 20 mg/kg (N = 16)

      Case8HPOsFreeText: 20 mg/kg GAA treatment, GAA activity at 8 pmol/punch/hr, GAA activity at 33% lower limit of normal

      CaseAddInfo: Late Onset Pompe Disease


      CaseGenotypingMethod: Method not described, only that the diagnosis was "confirmed … based on 2 GAA gene mutations"


      Variant1: NM_000152.4:c.-32-13T>G

      ClinVar: 4027 https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/

      gnomAD: Ashkenazi Jewish 5.541e-3, Overall 3.401e-3 https://gnomad.broadinstitute.org/variant/17-78078341-T-G


      Variant2: NM_000152.4:c.2242dupG (p.Glu748Glyfs)

      ClinVar: 370651 https://www.ncbi.nlm.nih.gov/clinvar/variation/370651/

      gnomAD: European (Non-Finnish) 1.767e-5, Overall 7.975e-6 https://gnomad.broadinstitute.org/variant/17-78090813-T-TG


      CaseAddInfo:

    1. c.1942G > A(p.Gly648Ser)

      Case34

      HPOsFreeText: See Group Phenotypes


      CasePreviousTesting: Sanger sequencing

      CaseMethod1: Sanger sequencing and PCR Amplification

      CaseMethod2: Whole Exome Sequencing (WES)

      CaseGenotypingMethod: Patients were previously confirmed with Pompe disease by Sanger sequencing to capture the pathogenic variants. The process was repeated as part of the study taking care to amplify the coding regions and exon/intron boundaries to compare with the WES results afterwards.


      Variant: NM_000152.4:c.1942G>A (p.Gly648Ser)

      ClinVar: 188902 https://www.ncbi.nlm.nih.gov/clinvar/variation/188902/

      gnomAD: South Asian 3.365e-4, Overall 5.361e-5 http://gnomad.broadinstitute.org/variant/17-78086728-G-A


      CaseAddInfo: Infantile Onset Pompe Disease, Patient is homozygous for this variant

    2. c.1796C > A(p.Ser599Tyr)

      Case56

      HPOsFreeText: See Group Phenotypes


      CasePreviousTesting: Sanger sequencing

      CaseMethod1: Sanger sequencing and PCR Amplification

      CaseMethod2: Whole Exome Sequencing (WES)

      CaseGenotypingMethod: Patients were previously confirmed with Pompe disease by Sanger sequencing to capture the pathogenic variants. The process was repeated as part of the study taking care to amplify the coding regions and exon/intron boundaries to compare with the WES results afterwards.


      Variant1: NM_000152.4:c.1796C>A (p.Ser599Tyr)

      ClinVar: 551558 https://www.ncbi.nlm.nih.gov/clinvar/variation/551558/

      gnomAD: European (Non-Finnish) 2.683e-5, Overall 1.207e-5 http://gnomad.broadinstitute.org/variant/17-78086418-C-A


      Variant2: NM_000152.4:c.-32-13T>G

      ClinVar: 4027 https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/

      gnomAD: Ashkenazi Jewish 5.541e-3, Overall 3.401e-3 http://gnomad.broadinstitute.org/variant/17-78078341-T-G


      CaseAddInfo: Juvenile Late Onset Pompe Disease

    3. c.784G > A(p.Glu262Lys)

      Case85

      HPOsFreeText: See Group Phenotypes


      CasePreviousTesting: Sanger sequencing

      CaseMethod1: Sanger sequencing and PCR Amplification

      CaseMethod2: Whole Exome Sequencing (WES)

      CaseGenotypingMethod: Patients were previously confirmed with Pompe disease by Sanger sequencing to capture the pathogenic variants. The process was repeated as part of the study taking care to amplify the coding regions and exon/intron boundaries to compare with the WES results afterwards.


      Variant1: NM_000152.4:c.784G>A (p.Glu262Lys)

      ClinVar: 188806 https://www.ncbi.nlm.nih.gov/clinvar/variation/188806/

      gnomAD: East Asian 5.016e-5, Overall 1.417e-5 http://gnomad.broadinstitute.org/variant/17-78081447-G-A


      Variant2: NM_000152.4:c.-32-13T>G

      ClinVar: 4027 https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/

      gnomAD: Ashkenazi Jewish 5.541e-3, Overall 3.401e-3 http://gnomad.broadinstitute.org/variant/17-78078341-T-G


      CaseAddInfo: Adult Late Onset Pompe Disease, 2 other patients have the same genotype

    4. c.1978C > T(p.Arg660Cys)

      Case10

      HPOsFreeText: See Group Phenotypes


      CasePreviousTesting: Sanger sequencing

      CaseMethod1: Sanger sequencing and PCR Amplification

      CaseMethod2: Whole Exome Sequencing (WES)

      CaseGenotypingMethod: Patients were previously confirmed with Pompe disease by Sanger sequencing to capture the pathogenic variants. The process was repeated as part of the study taking care to amplify the coding regions and exon/intron boundaries to compare with the WES results afterwards.


      Variant1: NM_000152.4:c.1978C>T (p.Arg660Cys)

      ClinVar: 558604 https://www.ncbi.nlm.nih.gov/clinvar/variation/558604/

      gnomAD: East Asian 5.554e-5, Overall 4.142e-6 http://gnomad.broadinstitute.org/variant/17-78086764-C-T


      Variant2: NM_000152.4:c.2221G>A (p.Asp741Asn)

      ClinVar: 571521 https://www.ncbi.nlm.nih.gov/clinvar/variation/571521/

      gnomAD: East Asian 1.087e-4, Overall 7.971e-6 http://gnomad.broadinstitute.org/variant/17-78090798-G-A


      CaseAddInfo: Infantile Onset Pompe Disease

    5. c.1075G > T(p.Gly359*)

      Case1

      HPOsFreeText: See Group Phenotypes


      CasePreviousTesting: Sanger sequencing

      CaseMethod1: Sanger sequencing and PCR Amplification

      CaseMethod2: Whole Exome Sequencing (WES)

      CaseGenotypingMethod: Patients were previously confirmed with Pompe disease by Sanger sequencing to capture the pathogenic variants. The process was repeated as part of the study taking care to amplify the coding regions and exon/intron boundaries to compare with the WES results afterwards.


      Variant: NM_000152.4:c.1075G>T (p.Gly359Ter)

      ClinVar: 420101 https://www.ncbi.nlm.nih.gov/clinvar/variation/420101/

      gnomAD: Not in gnomAD


      CaseAddInfo: Infantile Onset Pompe Disease, Patient is homozygous for this variant

    6. c.1411_1414del4(p.Glu471fs*5)

      Case27

      HPOsFreeText: See Group Phenotypes


      CasePreviousTesting: Sanger sequencing

      CaseMethod1: Sanger sequencing and PCR Amplification

      CaseMethod2: Whole Exome Sequencing (WES)

      CaseGenotypingMethod: Patients were previously confirmed with Pompe disease by Sanger sequencing to capture the pathogenic variants. The process was repeated as part of the study taking care to amplify the coding regions and exon/intron boundaries to compare with the WES results afterwards.


      Variant1: NM_000152.4:c.1411_1414delGAGA (p.Glu471fs*5)

      ClinVar: 188874 https://www.ncbi.nlm.nih.gov/clinvar/variation/188874/

      gnomAD: East Asian 2.513e-4, Overall 1.781e-5 http://gnomad.broadinstitute.org/variant/17-78083827-CGAGA-C


      Significance of this variant is unknown.

      Variant2: NM_000152.4:c.460_465del (Arg154_Thre155del)

      ClinVar: 551306 https://www.ncbi.nlm.nih.gov/clinvar/variation/551306/

      gnomAD: Not in gnomAD


      CaseAddInfo: Infantile Onset Pompe Disease

    7. c.2481+102_2646+31del (p.Gly828_Asn882del)

      Case39

      HPOsFreeText: See Group Phenotypes


      CasePreviousTesting: Sanger sequencing

      CaseMethod1: Sanger sequencing and PCR Amplification

      CaseMethod2: Whole Exome Sequencing (WES)

      CaseGenotypingMethod: Patients were previously confirmed with Pompe disease by Sanger sequencing to capture the pathogenic variants. The process was repeated as part of the study taking care to amplify the coding regions and exon/intron boundaries to compare with the WES results afterwards.


      Variant1: NM_000152.4:c.2481+102_2646+31del (p.Gly828_Asn882del) (exon 18 del)

      ClinVar: 4031 https://www.ncbi.nlm.nih.gov/clinvar/variation/4031/

      gnomAD: Not in gnomAD


      Variant2: NM_000152.4:c.525delT (p.Glu176Argfs*45)

      CAID: 4033 https://www.ncbi.nlm.nih.gov/clinvar/variation/4033/

      gnomAD: European (Non-Finnish) 1.880e-4, Overall 9.959e-5 http://gnomad.broadinstitute.org/variant/17-78078909-CT-C


      CaseAddInfo: Infantile Onset Pompe Disease, 1 more patient has the same genotype

    8. c.-32-17_-32-10delins TCCCTGCTGAGCCTCCTACAGGCCTCCCGC

      Case49

      HPOsFreeText: See Group Phenotypes


      CasePreviousTesting: Sanger sequencing

      CaseMethod1: Sanger sequencing and PCR Amplification

      CaseMethod2: Whole Exome Sequencing (WES)

      CaseGenotypingMethod: Patients were previously confirmed with Pompe disease by Sanger sequencing to capture the pathogenic variants. The process was repeated as part of the study taking care to amplify the coding regions and exon/intron boundaries to compare with the WES results afterwards.


      Variant1: NM_000152.4:c.-32-17_-32-10delins TCCCTGCTGAGCCTCCTACAGGCCTCCCGC

      CAID: CA913184750 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA913184750

      gnomAD: Not in gnomAD


      Variant2: NM_000152.4:c.1447G>A (p.Gly483Arg)

      ClinVar: 285157 https://www.ncbi.nlm.nih.gov/clinvar/variation/285157/

      gnomAD: African 6.170e-5, Overall 7.972e-6 http://gnomad.broadinstitute.org/variant/17-78084535-G-A


      CaseAddInfo: Infantile Onset Pompe Disease

    9. c.2560C > T(p.Arg854*)

      Case77

      HPOsFreeText: See Group Phenotypes


      CasePreviousTesting: Sanger sequencing

      CaseMethod1: Sanger sequencing and PCR Amplification

      CaseMethod2: Whole Exome Sequencing (WES)

      CaseGenotypingMethod: Patients were previously confirmed with Pompe disease by Sanger sequencing to capture the pathogenic variants. The process was repeated as part of the study taking care to amplify the coding regions and exon/intron boundaries to compare with the WES results afterwards.


      Variant1: NM_000152.4:c.2560C>T (p.Arg854*)

      ClinVar: 4034 https://www.ncbi.nlm.nih.gov/clinvar/variation/4034/

      gnomAD: African 1.891e-3, Overall 2.090e-4 http://gnomad.broadinstitute.org/variant/17-78092070-C-T


      Variant2: NM_000152.4:c.-32-13T>G

      ClinVar: 4027 https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/

      gnomAD: Ashkenazi Jewish 5.541e-3, Overall 3.401e-3 http://gnomad.broadinstitute.org/variant/17-78078341-T-G


      CaseAddInfo: Adult Late Onset Pompe Disease

    10. c.1327-2A > C

      Case30

      HPOsFreeText: See Group Phenotypes


      CasePreviousTesting: Sanger sequencing

      CaseMethod1: Sanger sequencing and PCR Amplification

      CaseMethod2: Whole Exome Sequencing (WES)

      CaseGenotypingMethod: Patients were previously confirmed with Pompe disease by Sanger sequencing to capture the pathogenic variants. The process was repeated as part of the study taking care to amplify the coding regions and exon/intron boundaries to compare with the WES results afterwards.


      Variant: NM_000152.4:c.1327-2A>C

      CAID: CA401366173 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.1327-2A%3EC

      gnomAD: Not in gnomAD


      CaseAddInfo: Infantile Onset Pompe Disease, Patient is homozygous for this variant

    11. c.1655T > C(p.Leu552Pro)

      Case53

      HPOsFreeText: See Group Phenotypes


      CasePreviousTesting: Sanger sequencing

      CaseMethod1: Sanger sequencing and PCR Amplification

      CaseMethod2: Whole Exome Sequencing (WES)

      CaseGenotypingMethod: Patients were previously confirmed with Pompe disease by Sanger sequencing to capture the pathogenic variants. The process was repeated as part of the study taking care to amplify the coding regions and exon/intron boundaries to compare with the WES results afterwards.


      Variant: NM_000152.4:c.1655T>C (p.Leu552Pro)

      ClinVar: 279811 https://www.ncbi.nlm.nih.gov/clinvar/variation/279811/

      gnomAD: European (Non-Finnish) 7.053e-5, Overall 3.188e-5 http://gnomad.broadinstitute.org/variant/17-78085800-T-C


      CaseAddInfo: Juvenile Late Onset Pompe Disease

    12. c.1143delC(p.Ala382Leufs*10)

      Case58

      HPOsFreeText: See Group Phenotypes


      CasePreviousTesting: Sanger sequencing

      CaseMethod1: Sanger sequencing and PCR Amplification

      CaseMethod2: Whole Exome Sequencing (WES)

      CaseGenotypingMethod: Patients were previously confirmed with Pompe disease by Sanger sequencing to capture the pathogenic variants. The process was repeated as part of the study taking care to amplify the coding regions and exon/intron boundaries to compare with the WES results afterwards.


      Variant1: NM_000152.4:c.1143delC (p.Ala382Leufs*10)

      CAID: 370263 https://www.ncbi.nlm.nih.gov/clinvar/variation/370263/

      gnomAD: European (Non-Finnish) 8.946e-6, Overall 4.031e-6 http://gnomad.broadinstitute.org/variant/17-78082353-AC-A


      Variant2: NM_000152.4:c.-32-13T>G

      ClinVar: 4027 https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/

      gnomAD: Ashkenazi Jewish 5.541e-3, Overall 3.401e-3 http://gnomad.broadinstitute.org/variant/17-78078341-T-G


      CaseAddInfo: Adult Late Onset Pompe Disease

    1. PD22

      Patient22: Female, Southern China

      CasePresentingHPOs:

      HPOsFreeText: IOPD

      CaseNotHPOs:

      NotHPOsFreeText:

      CaseAddInfo:

      CasePMIDs:

      CasePreviousTesting: same as group

      CaseGenotypingMethod: same as group

      Variant1: NM_000152.3:c.1241del

      CAID: CA913184736, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA913184736

      gnomAD: n/a

      Variant2: NM_000152.4(GAA):c.2662G>T (p.Glu888Ter)

      ClinVar: 578595, https://www.ncbi.nlm.nih.gov/clinvar/variation/578595/

      gnomAD: 1.65e-05, http://exac.broadinstitute.org/variant/17-78092467-G-T

    2. PD12

      Patient12: Male, Southern China

      CasePresentingHPOs:

      HPOsFreeText: IOPD

      CaseNotHPOs:

      NotHPOsFreeText:

      CaseAddInfo:

      CasePMIDs:

      CasePreviousTesting: same as group

      CaseGenotypingMethod: same as group

      Variant1: NM_000152.3:c.2585del

      CAID: CA913184734, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA913184734

      gnomAD: n/a

      Variant2: NM_000152.4(GAA):c.2815_2816delGT (p.Val939Leufs)

      ClinVar: 371481, https://www.ncbi.nlm.nih.gov/clinvar/variation/371481/

      gnomAD: 1.653e-05, http://exac.broadinstitute.org/variant/17-78093082-CTG-C

    3. PD17

      Patient17: Female, Southern China

      CasePresentingHPOs:

      HPOsFreeText: IOPD

      CaseNotHPOs:

      NotHPOsFreeText:

      CaseAddInfo:

      CasePMIDs:

      CasePreviousTesting: same as group

      CaseGenotypingMethod: same as group

      Variant1: NM_000152.4(GAA):c.1935C>A (p.Asp645Glu)

      ClinVar: 4029, https://www.ncbi.nlm.nih.gov/clinvar/variation/4029/

      gnomAD: 0.0001721, http://exac.broadinstitute.org/variant/17-78086721-C-A

      Variant2: NM_000152.4(GAA):c.2815_2816delGT (p.Val939Leufs)

      ClinVar: 371481, https://www.ncbi.nlm.nih.gov/clinvar/variation/371481/

      gnomAD: 1.653e-05, http://exac.broadinstitute.org/variant/17-78093082-CTG-C

    4. PD03

      Patient3: Male, northern China

      CasePresentingHPOs:

      HPOsFreeText: IOPD

      CaseNotHPOs:

      NotHPOsFreeText:

      CaseAddInfo:

      CasePMIDs:

      CasePreviousTesting: same as group

      CaseGenotypingMethod: same as group

      Variant1: NM_000152.3:c.2024A>G

      CAID: CA401370120, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA401370120

      gnomAD: n/a

      Variant2: NM_000152.4(GAA):c.2132C>G (p.Thr711Arg)

      ClinVar: 381006, https://www.ncbi.nlm.nih.gov/clinvar/variation/381006/

      gnomAD: 0.0001488, http://exac.broadinstitute.org/variant/17-78087108-C-G

    5. PD19

      Patient19: Male, Southern China

      CasePresentingHPOs:

      HPOsFreeText: IOPD

      CaseNotHPOs:

      NotHPOsFreeText:

      CaseAddInfo:

      CasePMIDs:

      CasePreviousTesting: same as group

      CaseGenotypingMethod: same as group

      Variant1: NM_000152.4(GAA):c.1935C>A (p.Asp645Glu)

      ClinVar: 4029, https://www.ncbi.nlm.nih.gov/clinvar/variation/4029/

      gnomAD: 0.0001721, http://exac.broadinstitute.org/variant/17-78086721-C-A

      Variant2: NM_000152.4(GAA):c.2815_2816delGT (p.Val939Leufs)

      ClinVar: 371481, https://www.ncbi.nlm.nih.gov/clinvar/variation/371481/

      gnomAD: 1.653e-05, http://exac.broadinstitute.org/variant/17-78093082-CTG-C

    6. PD11

      Patient11: Male, Southern China

      CasePresentingHPOs:

      HPOsFreeText: IOPD, survived beyond 2yo, left ventricular mass index and left ventricular posterior wall thickness decreased during ERT. Able to raise head, sit without support, stand, walk alone

      CaseNotHPOs: no significant respiratory problems during ERT

      NotHPOsFreeText:

      CaseAddInfo: homozygous, only patient to receive ERT treatment (rhGAA) every 2wks beginning at 5mo of age. ERT lasted for 90wks.

      CasePMIDs:

      CasePreviousTesting: same as group

      CaseGenotypingMethod: same as group

      Variant: NM_000152.4(GAA):c.1935C>A (p.Asp645Glu)

      ClinVar: 4029, https://www.ncbi.nlm.nih.gov/clinvar/variation/4029/

      gnomAD: 0.0001721, http://exac.broadinstitute.org/variant/17-78086721-C-A

    1. 11

      Case#: Patient 11, Gender N/A, Onset at 3-4 months. Death when 1-2 years old, Southeast Asian

      DiseaseAssertion: Parents are

      FamilyInfo: Proband parents are consanguineous family

      CasePresentingHPOs: HP:0001252, HP:0002240 Muscular hypotonia, Hepatomegaly

      CaseHPOFreeText: BVH, SDD

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: GAA enzyme activity is not available.

      PCR of all exons was performed and subsequently subjected to capillary Sanger sequencing in both directions

      Variant: NM_000152.5(GAA):c.1895T>G (p.Leu632Arg)

      ClinVar: 637961

      CAID: CA401369835

      gnomAD: N/A

      ParentalGenotype: Both parents were carriers of the variant c.1895T>G (p.Leu632Arg)

      PreviouslyPublished:

    2. 9

      Case#: Patient 9, Gender N/A, Onset at 3-4 months. Death around 1-2 years, Southeast Asian

      DiseaseAssertion: Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001252, HP:0001270, HP:0001640, HP:0005165

      Muscular hypotonia, Motor delay, Cardiomegaly, Shortened PR interval)

      CaseHPOFreeText: BVH, Ejection fraction 10%, Creatine kinase levels 1,010u/l

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: No GAA measurement . Ejection fraction 10%, Creatine kinase levels 1,010u/l

      PCR of all exons was performed and subsequently subjected to capillary Sanger sequencing in both directions

      Variant: NM_000152.5(GAA):c.1941C>G (p.Cys647Trp)

      ClinVar: 550327

      CAID: N/A

      gnomAD: Highes population MAF = 0.0001427 (Others)

      ParentalGenotype: Both parents were carriers for the viariant c.1941C>G (p.Cys647Trp)

      PreviouslyPublished: N/A

    1. P17

      Patient17: Male, 81yo

      CasePresentingHPOs: HP:0003077, HP:0000822

      HPOsFreeText: LOPD

      CaseNotHPOs:

      NotHPOsFreeText:

      CaseAddInfo: 6yr disease duration, ERT lasted 37mo

      CasePMIDs:

      CasePreviousTesting: same as group

      CaseGenotypingMethod: same as group

      Variant1: NM_000152.4(GAA):c.-32-13T>G

      Clinvar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/

      gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G

      Variant2: NM_000152.4(GAA):c.925G>A (p.Gly309Arg)

      ClinVar: 188797, https://www.ncbi.nlm.nih.gov/clinvar/variation/188797/

      gnomAD: 0.00002860, http://gnomad.broadinstitute.org/variant/17-78081665-G-A

    2. P4a

      Patient4: Male, 50yo

      CasePresentingHPOs: HP:0003077, HP:0005978

      HPOsFreeText: LOPD

      CaseNotHPOs:

      NotHPOsFreeText:

      CaseAddInfo: 5yr follow-up MRI, 18yr disease duration, ERT lasted 130mo

      CasePMIDs: PMID: 25614309

      CasePreviousTesting: same as group

      CaseGenotypingMethod: same as grou

      Variant1: NM_000152.4(GAA):c.-32-13T>G

      Clinvar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/

      gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G

      Variant2: NM_000152.3:c.1495T>A

      CAID: CA198789, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA198789

      gnomAD: n/a

    3. P3a

      Patient3: Male, 50yo

      CasePresentingHPOs: HP:0003077, HP:0000822

      HPOsFreeText: LOPD

      CaseNotHPOs:

      NotHPOsFreeText:

      CaseAddInfo: 5yr follow-up MRI, 40yr disease duration, ERT lasted for 116mo

      CasePMIDs: PMID: 25614309

      CasePreviousTesting: same as group

      CaseGenotypingMethod: same as group

      Variant1: NM_000152.4(GAA):c.-32-13T>G

      Clinvar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/

      gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G

      Variant2: c.2136-7delGT no ClinVar, no CAID

    4. P9

      Patient9: Male, 64yo

      CasePresentingHPOs: HP:0000822, HP:0000819, HP:0001513

      HPOsFreeText: LOPD

      CaseNotHPOs:

      NotHPOsFreeText:

      CaseAddInfo: 11yr disease duration, ERT lasted 14mo

      CasePMIDs: PMID: 25614309

      CasePreviousTesting: same as group

      CaseGenotypingMethod: same as group

      Variant1: NM_000152.4(GAA):c.-32-13T>G

      Clinvar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/

      gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G

      Variant2: NM_000152.4(GAA):c.925G>A (p.Gly309Arg)

      ClinVar: 188797, https://www.ncbi.nlm.nih.gov/clinvar/variation/188797/

      gnomAD: 0.00002860, http://gnomad.broadinstitute.org/variant/17-78081665-G-A

    1. #2

      Case#: Subject number 2, female, 7 years (report)

      DiseaseAssertion: Pompe disease

      FamilyInfo: Family member with PD

      CasePresentingHPOs:

      CaseHPOFreeText: Asymptomatic

      CaseNotHPOs: HP:0002153 (hyperkalemia), HP:0001324 (muscle weakness), HP:0003546 (Exercise intolerance), HP:0001252 (Hypotonia), HP:0003326 (Myalgia), HP:0002015 (dysphagia), HP:0002098 (respiratory distress), HP:0002094 (dyspnoea), HP:0001638 (cardiomyopathy)

      CaseNotHPOFreeText: no biopsy

      CasePreviousTesting: "Enzymatic activity was detected by fluorometric techniques" "The GAA sequence was performed in all patients whose enzyme activity measured in DBS and lymphocytes was decreased."

      glucosidase activity: GAA activity was 0.12 mol/Lh in dried blood spots (normal range >0.75).

      Variant 1: NM_000152.5(GAA):c.-32-13T>C

      Variant 1 ClinVarID: 4027

      Variant 1 CAid: CA116606

      Variant 2: NM_000152.5(GAA):c.1396_1397insG (p.Val466GlyfsTer?)

      Variant 2 ClinVarID: ?

      Variant 2 CAid: CA627699396

      Zygosity: Compound heterozygous

      ParentalGenotype: N/A

      PreviouslyPublished: N/A

    2. #5

      Case#: Subject number 5, female, 17 years (report)

      DiseaseAssertion: Pompe disease

      FamilyInfo: No known family member with PD

      CasePresentingHPOs: HP:0002153 (hyperkalemia), HP:0001324 (muscle weakness), HP:0003546 (Exercise intolerance)

      CaseHPOFreeText: Biopsy

      CaseNotHPOs: HP:0001638 (cardiomyopathy), HP:0001252 (Hypotonia), HP:0003326 (Myalgia), HP:0002015 (dysphagia), HP:0002098 (respiratory distress), HP:0002094 (dyspnoea)

      CaseNotHPOFreeText: not asymptomatic

      CasePreviousTesting: "Enzymatic activity was detected by fluorometric techniques" "The GAA sequence was performed in all patients whose enzyme activity measured in DBS and lymphocytes was decreased."

      glucosidase activity: GAA activity was 0.37 mol/Lh in dried blood spots (normal range >0.75).

      Variant 1: NM_000152.5(GAA):c.1328A>T (p.Asp443Val)

      Variant 1 ClinVarID: N/A

      Variant 1 CAid: CA401366199

      Variant 2: NM_000152.5(GAA):c.1328A>T (p.Asp443Val)

      Variant 2 ClinVarID: N/A

      Variant 2 CAid: CA401366199

      Zygosity: homozygous

      ParentalGenotype: N/A

      PreviouslyPublished: N/A

    3. #9

      Case#: Subject number 9, female, 44 years (report)

      DiseaseAssertion: Pompe disease

      FamilyInfo: No known family member with PD

      CasePresentingHPOs: HP:0001638 (cardiomyopathy), HP:0002098 (respiratory distress)

      CaseHPOFreeText:

      CaseNotHPOs: HP:0002153 (hyperkalemia), HP:0001324 (muscle weakness), HP:0003546 (Exercise intolerance), HP:0001252 (Hypotonia), HP:0003326 (Myalgia), HP:0002015 (dysphagia), HP:0002094 (dyspnoea)

      CaseNotHPOFreeText: no biopsy, not asymptomatic

      CasePreviousTesting: "Enzymatic activity was detected by fluorometric techniques" "The GAA sequence was performed in all patients whose enzyme activity measured in DBS and lymphocytes was decreased."

      glucosidase activity: GAA activity was 0.34 mol/Lh in dried blood spots (normal range >0.75).

      Variant 1: NM_000152.5(GAA):c.-32-13T>C

      Variant 1 ClinVarID: 4027

      Variant 1 CAid: CA116606

      Variant 2: NM_000152.5(GAA):c.2819C>A (p.Ser940Ter)

      Variant 2 ClinVarID: ?

      Variant 2 CAid: CA401327757

      Zygosity: Compound heterozygous

      ParentalGenotype: N/A

      PreviouslyPublished: N/A

    4. #18

      Case#: Subject number 18, female, 79 years (report)

      DiseaseAssertion: Pompe disease

      FamilyInfo: Family member with PD

      CasePresentingHPOs:

      CaseHPOFreeText: Asymptomatic

      CaseNotHPOs: HP:0002153 (hyperkalemia), HP:0001324 (muscle weakness), HP:0003326 (Myalgia), HP:0002015 (dysphagia), HP:0001252 (Hypotonia), HP:0001638 (cardiomyopathy), HP:0002098 (respiratory distress), HP:0003546 (Exercise intolerance), HP:0002094 (dyspnoea)

      CaseNotHPOFreeText: no biopsy

      CasePreviousTesting: "Enzymatic activity was detected by fluorometric techniques" "The GAA sequence was performed in all patients whose enzyme activity measured in DBS and lymphocytes was decreased."

      glucosidase activity: GAA activity was 0.65 mol/Lh in dried blood spots (normal range >0.75).

      Variant 1: NM_000152.5(GAA):c.854C>G (p.Pro285Arg)

      Variant 1 ClinVarID: 225114

      Variant 1 CAid: CA358045

      Variant 2: N/A

      Variant 2 ClinVarID: N/A

      Variant 2 CAid: N/A

      Zygosity: Heterozygous

      ParentalGenotype: N/A

      PreviouslyPublished: N/A

    1. 15

      Case15: Female, 39 years onset, 40 years diagnosis, Italy

      HPOsFreeText: See Group Phenotypes, ERT started at 41, GAA Activity at ~6.5 pmol/min/mg before ERT and ~11 after

      GroupGenotypingMethod: PCR Amplification and GAA Gene Sequencing


      Variant1: NM_000152.4:c.-32-13T>G

      ClinVar: 4027 https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/

      gnomAD: Ashkenazi Jewish 5.541e-3, Overall 3.401e-3 http://gnomad.broadinstitute.org/variant/17-78078341-T-G


      Variant2: NM_000152.4:c.2237G>A (p.Trp746Ter)

      ClinVar: 280063 https://www.ncbi.nlm.nih.gov/clinvar/variation/280063/

      gnomAD: European (Non-Finnish) 8.834e-6, Overall 3.988e-6 http://gnomad.broadinstitute.org/variant/17-78090814-G-A


      CaseAddInfo: Late Onset Pompe Disease

    2. 14

      Case14: Female, 15 years onset, 16 years diagnosis, Italy

      HPOsFreeText: See Group Phenotypes, ERT started at 16, GAA Activity at ~8 pmol/min/mg before ERT and ~12 after

      GroupGenotypingMethod: PCR Amplification and GAA Gene Sequencing


      Variant1: NM_000152.4:c.-32-13T>G

      ClinVar: 4027 https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/

      gnomAD: Ashkenazi Jewish 5.541e-3, Overall 3.401e-3 http://gnomad.broadinstitute.org/variant/17-78078341-T-G


      Variant2: NM_000152.4:c.1927G>A (p.Gly643Arg)

      ClinVar: 4023 https://www.ncbi.nlm.nih.gov/clinvar/variation/4023/

      gnomAD: European (Non-Finnish) 3.667e-5, Overall 2.479e-5 http://gnomad.broadinstitute.org/variant/17-78086713-G-A


      CaseAddInfo: Late Onset Pompe Disease

    1. 16

      Patient16: 16yo

      CasePresentingHPOs: HP:0003325, HP:0020038

      HPOsFreeText: GAA = 4.5%, BMI = 21.4, fetal origin of right posterior cerebral artery, normal CT

      CaseNotHPOs:

      NotHPOsFreeText: No cardiovascular risk

      CaseAddInfo: 6yr disease duration, variants in trans

      CasePMIDs:

      CasePreviousTesting: same as group

      CaseGenotypingMethod: same as group

      Variant1: NM_000152.4(GAA):c.-32-13T>G

      Clinvar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/

      gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G

      Variant2: NM_000152.3:c.2530_2541del

      CAID: CA658795292, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA658795292

      gnomAD: n/a

    2. 17

      Patient17: 65yo

      CasePresentingHPOs: HP:0003325, HP:0002093, HP:0002870, HP:0020038, HP:0002637

      HPOsFreeText: GAA = 6.8%, smoker, BMI = 27.1, right ventricular trigone retraction due to ischemia

      CaseNotHPOs:

      NotHPOsFreeText:

      CaseAddInfo: 22yr disease duration, variants in cis

      CasePMIDs:

      CasePreviousTesting: same as group

      CaseGenotypingMethod: same as group

      Variant1: NM_000152.4(GAA):c.-32-13T>G

      Clinvar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/

      gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G

      Variant2: NM_000152.4(GAA):c.1561G>A (p.Glu521Lys)

      ClinVar: 4022, https://www.ncbi.nlm.nih.gov/clinvar/variation/4022/

      gnomAD: 8.262e-06, http://exac.broadinstitute.org/variant/17-78084749-G-A

    3. 20

      Patient20: 60yo

      CasePresentingHPOs: HP:0003325, HP:0002093, HP:0000822, HP:0002870, HP:0020038

      HPOsFreeText: GAA = 11%, BMI = 23.2, subcortical white matter lacunes

      CaseNotHPOs:

      NotHPOsFreeText:

      CaseAddInfo: 5yr disease duration, variants in cis

      CasePMIDs:

      CasePreviousTesting: same as group

      CaseGenotypingMethod: same as group

      Variant1: NM_000152.4(GAA):c.-32-13T>G

      Clinvar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/

      gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G

      Variant2: NM_000152.4(GAA):c.1561G>A (p.Glu521Lys)

      ClinVar: 4022, https://www.ncbi.nlm.nih.gov/clinvar/variation/4022/

      gnomAD: 8.262e-06, http://exac.broadinstitute.org/variant/17-78084749-G-A

    1. Detailed characteristics of these patients

      Patient1: female, 29yo, juvenile onset

      CasePresentingHPOs:

      HPOsFreeText: LOPD, BMI = 19.6;20.3;21, BiPAP use required at last follow-up, WGMS = 3;3;4

      CaseNotHPOs: HP:0002355

      NotHPOsFreeText:

      CaseAddInfo:

      CasePMIDs:

      CasePreviousTesting: same as group

      CaseGenotypingMethod: same as group

      Variant1: NM_000152.4(GAA):c.2014C>T (p.Arg672Trp)

      ClinVar: 188773, https://www.ncbi.nlm.nih.gov/clinvar/variation/188773/

      gnomAD: 0.000008290, http://gnomad.broadinstitute.org/variant/17-78086800-C-T

      Variant2: NM_000152.3:c.1703A>T

      CAID: CA401369027, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA401369027

      gnomAD: n/a

    2. Detailed characteristics of these patients

      Patient5: female, 53yo, adult onset

      CasePresentingHPOs:

      HPOsFreeText: LOPD, BMI = 21.1 / 21.1 / 22.5, WGMS = 3 / 3 / 3

      CaseNotHPOs: HP:0002355

      NotHPOsFreeText: did not require respiratory support

      CaseAddInfo:

      CasePMIDs:

      CasePreviousTesting: same as group

      CaseGenotypingMethod: same as group

      Variant1: NM_000152.4(GAA):c.-32-13T>G

      Clinvar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/

      gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G

      Variant2: NM_000152.4(GAA):c.525delT (p.Glu176Argfs)

      ClinVar: 4033, https://www.ncbi.nlm.nih.gov/clinvar/variation/4033/

      gnomAD: 0.00009959, http://gnomad.broadinstitute.org/variant/17-78078909-CT-C

    1. For GAA (Pompe disease) screening

      CaseP1-GAA: Male, ethnicity = North African, country origin = Morocco

      CasePresentingHPOs: HP:0010899, HP:0010916, HP:0003236

      HPOsFreeText: enzyme activity = 0.61, CPK = 448 U/L, ALT = 48 U/L, AST = 98 U/L, CRIM positive

      CaseNotHPOs:

      NotHPOsFreeText:

      CaseAddInfo: heterozygote, variants in trans. Patient underwent ERT.

      CasePreviousTesting: initial and confirmatory DBS, biochemical tests, echocardiography

      CaseGenotypingMethod: mutation analyses

      Variant1: NM_000152.4(GAA):c.-32-13T>G

      Clinvar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/

      gnomAD: n/a

      Variant2: NM_000152.4(GAA):c.236_246delCCACACAGTGC (p.Pro79Argfs)

      ClinVar: 371302, https://www.ncbi.nlm.nih.gov/clinvar/variation/371302/

      gnomAD: n/a

    1. 31

      Case#: Subject number 31(L)

      DiseaseAssertion: Late Onset Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: N/A

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      glucosidase activity: GAA activity #2 (NBS) 0.94 in dried blood spots (>2.10 micromole/L/h is normal).

      Variant 1: NM_000152.5(GAA):c.-32-13T>G

      Variant 1 ClinVarID: 4027

      Variant 1 CAid: CA116606

      Variant 2: NM_000152.5(GAA):c.2238G>C

      Variant 2 ClinVarID: 265160

      Variant 2 CAid: CA8815665

      Variant 3: NM_000152.5(GAA):c.2065G>A

      Variant 3 ClinVarID: 4030

      Variant 3 CAid: CA116612

      Zygosity: compound heterozygous

      ParentalGenotype: N/A

      PreviouslyPublished: N/A

    2. 10

      Case#: Subject number 10(L)

      DiseaseAssertion: Late Onset Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: N/A

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: CK testing: 617 U/L (60-305 U/L is normal), Hex4: 6.6 mmol/mol Creatinine (≤20 mmol/mol Creatinine is normal)

      glucosidase activity: GAA activity #1 was 0.84 micromole/L/h and GAA activity #2 (NBS) 0.49 in dried blood spots (>2.10 micromole/L/h is normal). 2.1 in confirmatory testing (>3.88 is normal).

      Variant 1: NM_000152.5(GAA):c.1438-1G>C

      Variant 1 ClinVarID: 189184

      Variant 1 CAid: CA274472

      Variant 2: NM_000152.5(GAA):c.-32-13T>G

      Variant 2 ClinVarID: 4027

      Variant 2 CAid: CA116606

      Zygosity: compound heterozygous

      ParentalGenotype: N/A

      PreviouslyPublished: N/A

    1. 22a

      Patient22: Female, 40yo at diagnosis and ERT

      CasePresentingHPOs:

      HPOsFreeText: anti rh-GAA antibodies titre = 1:12,800, enzyme = 2.77 pmol/punch/h (7.3–39), NIV and mobility aid required before and after ERT

      CaseNotHPOs:

      NotHPOsFreeText:

      CaseAddInfo: 18yr disease duration, patient discontinued ERT, variants in trans

      CasePMIDs:

      CasePreviousTesting: same as group

      CaseGenotypingMethod: same as group

      Variant1: NM_000152.4(GAA):c.-32-13T>G

      Clinvar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/

      gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G

      Variant2: NM_000152.4(GAA):c.258dupC (p.Asn87Glnfs)

      ClinVar: 282842, https://www.ncbi.nlm.nih.gov/clinvar/variation/282842/

      gnomAD: 2.653e-05, http://exac.broadinstitute.org/variant/17-78078636-T-TC

    2. 8

      Patient8: Female, 41yo at diagnosis, 48yo at ERT

      CasePresentingHPOs:

      HPOsFreeText: anti rh-GAA antibodies titre = 1:1600, enzyme (μmol/g/h) = 0.23 (2-10), mobility aid required before and after ERT

      CaseNotHPOs:

      NotHPOsFreeText: NIV not required

      CaseAddInfo: 7yr disease duration, variants in trans

      CasePMIDs:

      CasePreviousTesting: same as group

      CaseGenotypingMethod: same as group

      Variant1: NM_000152.3:c.482_483del

      CAID: CA8814879, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA8814879

      gnomAD: 1.729e-05, http://exac.broadinstitute.org/variant/17-78078864-TCC-T

      Variant2: NM_000152.4(GAA):c.692+5G>T

      ClinVar: 562532, https://www.ncbi.nlm.nih.gov/clinvar/variation/526532/

      gnomAD: 8.596e-06, http://exac.broadinstitute.org/variant/17-78079698-G-T

    1. 18/M

      Patient18: Male

      CasePresentingHPOs: HP:0004887, HP:0001270, HP:0002546

      HPOsFreeText: CRIM positive, Anti-rh GGA antibodies maximum titer = ≤ 1:400, heart normalization

      CaseNotHPOs: HP:0025156, HP:0000365, HP:0001371

      NotHPOsFreeText: infusion associated reaction

      CaseAddInfo: homozygous variants in trans, symptom onset at 1yo, diagnosis at 1.5yo, ERT at 4yo

      CasePreviousTesting: same as group

      CaseGenotypingMethod: same as group

      Variant: NM_000152.4(GAA):c.784G>A (p.Glu262Lys)

      ClinVar: 188806, https://www.ncbi.nlm.nih.gov/clinvar/variation/188806/

      gnomAD: 1.66e-05, http://exac.broadinstitute.org/variant/17-78081447-G-A

    2. 24/F

      Patient24: Female

      CasePresentingHPOs: HP:0000365

      HPOsFreeText: CRIM positive, heart normalization

      CaseNotHPOs: HP:0004887, HP:0025156, HP:0002355, HP:0002546, HP:0001371

      NotHPOsFreeText: infusion associated reaction

      CaseAddInfo: variants in trans, symptom onset at 2yo, diagnosis at 3yo, ERT at 4yo

      CasePreviousTesting: same as group

      CaseGenotypingMethod: same as group

      Variant1: NM_000152.4(GAA):c.1933G>A (p.Asp645Asn)

      ClinVar: 188728, https://www.ncbi.nlm.nih.gov/clinvar/variation/188728/

      gnomAD: 0.000008250, http://gnomad.broadinstitute.org/variant/17-78086719-G-A

      Variant2: NM_000152.3:c.1822C>T

      CAID: CA8815488, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.3%3Ac.1822C%3ET

      gnomAD: 0.00001806, http://gnomad.broadinstitute.org/variant/17-78086444-C-T

    3. 27/M

      Patient27: Male

      CasePresentingHPOs: HP:0000365

      HPOsFreeText: CRIM positive, Anti-rh GGA antibodies maximum titer = ≤ 1:400, moderate periventricular white matter abnormalities (hypomyelination), progressive deterioration of MRI parameters

      CaseNotHPOs: HP:0004887, HP:0025156, HP:0002355, HP:0002546, HP:0001371

      NotHPOsFreeText: infusion associated reaction, heart normalization

      CaseAddInfo: variants in trans, symptom onset at birth, diagnosis at 3yo, ERT at 4yo

      CasePreviousTesting: same as group

      CaseGenotypingMethod: same as group

      Variant1: NM_000152.4(GAA):c.1465G>A (p.Asp489Asn)

      ClinVar: 92465, https://www.ncbi.nlm.nih.gov/clinvar/variation/92465/

      gnomAD: 0.00001195, http://gnomad.broadinstitute.org/variant/17-78084553-G-A

      Variant2: NM_000152.3:c.40_47del

      CAID: CA913184761, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA913184761

      gnomAD: n/a

    1. Supplement Table 1)

      Patient7: 6yo

      CasePresentingHPOs: HP:0001638

      HPOsFreeText: rhGAA dosage = 20 QW, independent walker

      CaseNotHPOs:

      NotHPOsFreeText:

      CaseAddInfo: 12days old at ERT start

      CasePMIDs:

      CasePreviousTesting: same as group

      CaseGenotypingMethod: same as group

      Variant1: NM_000152.4(GAA):c.1935C>A (p.Asp645Glu)

      ClinVar: 4029, https://www.ncbi.nlm.nih.gov/clinvar/variation/4029/

      gnomAD: 0.0001721, http://exac.broadinstitute.org/variant/17-78086721-C-A

      Variant2: NM_000152.3:c.1062C>G

      CAID: CA401364789, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA401364789

      gnomAD: n/a

      Variant3: NM_000152.4(GAA):c.1286A>G (p.Gln429Arg)

      ClinVar: 284497, https://www.ncbi.nlm.nih.gov/clinvar/variation/284497/

      gnomAD: 0.0007528, http://gnomad.broadinstitute.org/variant/17-78082587-A-G

    2. Supplement Table 1)

      Patient11: 4yo

      CasePresentingHPOs: HP:0001638

      HPOsFreeText: rhGAA dosage = 20 EOW, independent walker

      CaseNotHPOs:

      NotHPOsFreeText:

      CaseAddInfo: 2mo at ERT start

      CasePMIDs:

      CasePreviousTesting: same a group

      CaseGenotypingMethod: same as group

      Variant1: NM_000152.3:c.872T>C

      CAID: CA401363854, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA401363854

      gnomAD: n/a

      Variant2: NM_000152.3:c.1798C>T

      CAID: CA8815481, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA8815481

      gnomAD: 8.669e-06, http://exac.broadinstitute.org/variant/17-78086420-C-T

    1. 17

      Case#: Subject number 17, female, 33 years (report), 14 years (onset), 24 years (diagnosis)

      DiseaseAssertion: Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0000360 (tinnitus)

      CaseHPOFreeText: ambulatory

      CaseNotHPOs: HP:0009830, HP:0002650, HP:0000939, HP:0000821, HP:0000365, HP:0002617, HP:0100647, HP:0010788, HP:0001638 (peripheral neuropathy, scoliosis, osteoporosis, hypothyroidism, hearing loss, aneurysm, Graves disease, Testicular cancer, cardiomyopathy)

      CaseNotHPOFreeText: no infusion reaction, no tracheostomy, not on BiPAP

      CasePreviousTesting: “documented deficiency of acid alpha-glucosidase enzyme activity”; on enzyme replacement therapy

      Variant 1: NM_000152.5(GAA):c.-32-13T>G (p.Tyr766Ser)

      Variant 1 ClinVarID: 4027

      Variant 1 CAid: CA116606

      Variant 2: NM_000152.5(GAA):c.2104C>T

      Variant 2 ClinVarID: 189040

      Variant 2 CAid: CA274304

      Zygosity: Compound heterozygous

      ParentalGenotype: N/A

    2. 3

      Case#: Subject number 3, male, 56 years (report), 30s years (onset), 48 years (diagnosis)

      DiseaseAssertion: Pompe disease

      FamilyInfo: N/A ** CasePresentingHPOs**: HP:0000365 (hearing loss), HP:0000360 (tinnitus)

      CaseHPOFreeText: ambulatory

      CaseNotHPOs: HP:0002617, HP:0000939, HP:0009830, HP:0100647, HP:0010788, HP:0000821, HP:0002650, HP:0001638 (aneurysm, osteoporosis, peripheral neuropathy, Graves disease, Testicular cancer, hypothyroidism, scoliosis, cardiomyopathy)

      CaseNotHPOFreeText: No infusion reaction, no tracheostomy, not on BiPAP

      CasePreviousTesting: “documented deficiency of acid alpha-glucosidase enzyme activity”; on enzyme replacement therapy

      Variant 1: NM_000152.5(GAA):c.-32-13T>G (p.Tyr766Ser)

      Variant 1 ClinVarID: 4027

      Variant 1 CAid: CA116606

      Variant 2: NM_000152.5(GAA):c.2431delC (p.Leu811TrpfsTer?)

      Variant 2 ClinVarID: N/A

      Variant 2 CAid: CA628018649

      Zygosity: Compound heterozygous

      ParentalGenotype: N/A

      PreviouslyPublished: N/A

    3. 16

      Case#: Subject number 16, male, 64 years (report), 56 years (onset), 60 years (diagnosis)

      DiseaseAssertion: Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs:

      CaseHPOFreeText: on BiPAP, ambulatory, assistive device (cane)

      CaseNotHPOs: HP:0009830, HP:0000360, HP:0002650, HP:0000939, HP:0000821, HP:0000365, HP:0002617, HP:0100647, HP:0010788, HP:0001638 (peripheral neuropathy, tinnitus, scoliosis, osteoporosis, hypothyroidism, hearing loss, aneurysm, Graves disease, Testicular cancer, cardiomyopathy)

      CaseNotHPOFreeText: no infusion reaction, no tracheostomy

      CasePreviousTesting: “documented deficiency of acid alpha-glucosidase enzyme activity”; on enzyme replacement therapy

      Variant 1: NM_000152.5(GAA):c.-32-13T>G (p.Tyr766Ser)

      Variant 1 ClinVarID: 4027

      Variant 1 CAid: CA116606

      Variant 2: NM_000152.5(GAA):c.307T>G

      Variant 2 ClinVarID: 92483

      Variant 2 CAid: CA220404

      Zygosity: Compound heterozygous

      ParentalGenotype: N/A

    4. 8

      Case#: Subject number 8, female, 49 years (report), 20s years (onset), 42 years (diagnosis)

      DiseaseAssertion: Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0000821 (hypothyroidism)

      CaseHPOFreeText: ambulatory, assistive device (quad cane, wheelchair)

      CaseNotHPOs: HP:0000365, HP:0002650, HP:0000360, HP:0002617, HP:0000939, HP:0009830, HP:0100647, HP:0010788, HP:0001638 (hearing loss, scoliosis, tinnitus, aneurysm, osteoporosis, peripheral neuropathy, Graves disease, Testicular cancer, cardiomyopathy)

      CaseNotHPOFreeText: No infusion reaction, no tracheostomy, not on BiPAP

      CasePreviousTesting: “documented deficiency of acid alpha-glucosidase enzyme activity”; on enzyme replacement therapy

      Variant 1: NM_000152.5(GAA):c.-32-13T>G (p.Tyr766Ser)

      Variant 1 ClinVarID: 4027

      Variant 1 CAid: CA116606

      Variant 2: NM_000152.5(GAA):c.1437+2T>C

      Variant 2 ClinVarID: 849313

      Variant 2 CAid: CA401366685

      Zygosity: Compound heterozygous

      ParentalGenotype: N/A

      PreviouslyPublished: N/A

    5. 5

      Case#: Subject number 5, male, 59 years (report), 10 years (onset), 33 years (diagnosis)

      DiseaseAssertion: Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0000365 (hearing loss), HP:0000360 (tinnitus), HP:0000939 (osteoporosis)

      CaseHPOFreeText: Tracheostomy, assistive device (wheelchair)

      CaseNotHPOs: HP:0002650, HP:0002617, HP:0009830, HP:0100647, HP:0010788, HP:0000821, HP:0001638 (scoliosis, aneurysm, peripheral neuropathy, Graves disease, Testicular cancer, hypothyroidism, cardiomyopathy)

      CaseNotHPOFreeText: No infusion reaction, no ambulatory, not on BiPAP

      CasePreviousTesting: “documented deficiency of acid alpha-glucosidase enzyme activity”; on enzyme replacement therapy

      Variant 1: NM_000152.5(GAA):c.-32-13T>G (p.Tyr766Ser)

      Variant 1 ClinVarID: 4027

      Variant 1 CAid: CA116606

      Variant 2: NM_000152.5(GAA):c.925G>A (p.Gly309Arg)

      Variant 2 ClinVarID: 188797

      Variant 2 CAid: CA273972

      Zygosity: Compound heterozygous

      ParentalGenotype: N/A

      PreviouslyPublished: N/A

    1. P2

      Patient2: Female, 1.5mo at diagnosis, 3mo at ERT

      CasePresentingHPOs:

      HPOsFreeText: classic IOPD, good response to ERT, Pompe muscle pathology score = 2.1(a), 0.5(b), Glycogen = 48.7(a), 2.7(b) Vv(PAS + /mf)%, Larger empty vacuoles = 1.7(a), 5.6(b) Vv (LEV/mf)%, Autophagic vacuoles = 0,15; 0,2 %/mf

      CaseNotHPOs:

      NotHPOsFreeText:

      CaseAddInfo: biopsy taken from  musculus vastus lateralis

      CasePMIDs:

      CasePreviousTesting: same as group

      CaseGenotypingMethod: same as group

      Variant1: NM_000152.4(GAA):c.1933G>A (p.Asp645Asn)

      ClinVar: 188728, https://www.ncbi.nlm.nih.gov/clinvar/variation/188728/

      gnomAD: 2.312e-05, http://exac.broadinstitute.org/variant/17-78086719-G-A

      Variant2: NM_000152.3:c.794delG

      CAID: CA658795237, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.3%3Ac.794delG

      gnomAD: n/a

    2. P5

      Patient5: Female, 4.5mo at diagnosis, 5mo at ERT

      CasePresentingHPOs:

      HPOsFreeText: classic IOPD, poor response to ERT, Pompe muscle pathology score = 1.7, Glycogen = 26.9 Vv(PAS + /mf)%, larger empty vacuoles = 9.9 Vv (LEV/mf)%, Autophagic vacuoles = 2,91 %/mf

      CaseNotHPOs:

      NotHPOsFreeText:

      CaseAddInfo: homozygous variant, biopsy taken from  musculus vastus lateralis

      CasePMIDs:

      CasePreviousTesting: same as group

      CaseGenotypingMethod: same as group

      Variant: NM_000152.3:c.1456G>C

      CAID: CA401366835, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA401366835

      gnomAD: n/a

    1. 4

      Case#: 4, age 24, age 18 (report)

      DiseaseAssertion: Pompe Disease

      FamilyInfo: Family 4, no further information

      CasePresenting HPOs:HP:0012378, HP:0003546, HP:0001324 (fatigue, exercise intolerance, muscle weakness)

      CaseHPOFreeText: vacuolar myopathy biopsy PAS +

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: single gene sequencing/analysis, 40.54 NaG/AaGIA, 90.54% inhibition of GAA; NaG/AaGIA above 40 and %INH above 87 are in the affected range

      Variants:

      Variant 1:NM_000152.5(GAA):c.2608C>T (p.Arg870Ter)

      ClinVar: 189009

      Variant 2: not reported

      ParentalGenotypes: N/A

      PreviouslyPublished: N/A

    1. 1

      Case1: Female, Danish, 38 years report, 25 years onset

      CasePresentingHPOs: HP:0008956 (Thigh muscle atrophy)

      HPOsFreeText: 6-min walk test achieved 531 m, MRC score is 4/5 (thigh/calf), Forced vital capacity sitting/supine is 2.8/2.2 (L)

      NotHPOsFreetext: Not on ERT

      GroupGenotypingMethod: Mutation Analysis on the GAA Gene


      Variant1: NM_000152.4:c.-32-13T>A

      CAID: CA913184742 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA913184742

      gnomAD: Not in gnomAD


      Variant2: NM_000152.4:c.307T>G (p.Cys103Gly)

      ClinVar: 92483 https://www.ncbi.nlm.nih.gov/clinvar/variation/92483/

      gnomAD: European (Non-Finnish) 7.874e-6, Overall 3.578e-6 http://gnomad.broadinstitute.org/variant/17-78078692-T-G


      CaseAddInfo: Late Onset Pompe Disease

    2. 7

      Case7: Male, Danish, 20 years report, 1 year onset

      HPOsFreeText: MRC score is 4/5 (thigh/calf), Forced vital capacity sitting/supine is 5.6/5.3 (L), Has started ERT

      CaseNotHPOs: HP:0008956 (Thigh muscle atrophy)

      GroupGenotypingMethod: Mutation Analysis on the GAA Gene


      Variant1: NM_000152.4:c.2228A>G (p.Gln743Arg)

      CAID: CA401324753 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.2228A%3EG

      gnomAD: Not in gnomAD


      Variant2: NM_000152.4:c.2237G>C (p.Trp746Ser)

      ClinVar: 188484 https://www.ncbi.nlm.nih.gov/clinvar/variation/188484/

      gnomAD: African 3.210e-4, Overall 7.089e-5 http://gnomad.broadinstitute.org/variant/17-78090814-G-C


      Variant3: NM_000152.4:c.-32-13T>G

      ClinVar: 4027 https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/

      gnomAD: Ashkenazi Jewish 5.541e-3, Overall 3.401e-3 http://gnomad.broadinstitute.org/variant/17-78078341-T-G


      CaseAddInfo: Late Onset Pompe Disease, Nomenclature indicates Variants 1 and 2 are in cis

    3. 4

      Case4: Male, French, 65 years report, 55 years onset

      HPOsFreeText: 6-min walk test achieved 540 m, MRC score is 5/5 (thigh/calf), Forced vital capacity sitting/supine is 2.7/1.8 (L), On the medications Statin and Allopurinol, Has started ERT

      CaseNotHPOs: HP:0008956 (Thigh muscle atrophy)

      GroupGenotypingMethod: Mutation Analysis on the GAA Gene


      Variant1: NM_000152.4:c.-32-13T>A

      CAID: CA913184742 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA913184742

      gnomAD: Not in gnomAD


      Variant2: NM_000152.4:c.3G>A

      CAID: CA401359809 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.3G%3EA

      gnomAD: European (Non-Finnish) 8.945e-6, Overall 4.041e-6 http://gnomad.broadinstitute.org/variant/17-78078388-G-A


      CaseAddInfo: Late Onset Pompe Disease

    1. Patient Number 1

      Case1: Male, 31 years report, 12 years onset, Algeria, African

      CasePresentingHPOs: HP:0003749, HP:0002355, HP:0003551, HP:0008997, HP:0003484, HP:0002875, HP:0002315, HP:0002938, HP:0002515, HP:0008994, HP:0009129, HP:0007210, HP:0008981, HP:0006844, HP:0002091, HP:0003236, HP:0003198, HP:0003560 (Pelvic girdle muscle weakness, Difficulty walking, Difficulty climbing stairs, Proximal muscle weakness in upper limbs, Upper limb muscle weakness, Exertional dyspnea, Headache, Lumbar hyperlordosis, Waddling gait, Proximal muscle weakness in lower limbs, Upper limb amyotrophy, Lower limb amyotrophy, Calf muscle hypertrophy, Absent patellar reflexes, Restrictive lung disease, Increased serum CK, Myopathic changes, Muscular dystrophy)

      HPOsFreeText: Severe proximal weakness of paraspinal muscles, At grade 3 of Vignos and Walton scales, Serum CK activity was 4 times the normal value and AST and ALT were 3 times the normal value, GAA activity measured in leukocytes was reduced to about 6% of control values, Became wheelchair-dependent at the age of 27 years

      CaseNotHPOs: HP:0003115, HP:0003116, HP:0001270, HP:0001290, HP:0002240, HP:0001640 (Abnormal ECG, Abnormal echocardiography, Motor delay, Generalized hypotonia, Hepatomegaly, Cardiomegaly)

      CaseAddInfo: Proband had one affected parental cousin, Patient 2, who died from respiratory problems in 2008

    2. Patient Number 5

      Case5: Female, 11 months report and onset, Algeria, African

      CasePresentingHPOs: HP:0002098, HP:0002883, HP:0000961, HP:0030829, HP:0001290, HP:0003236, HP:0003198, HP:0002878 (Respiratory distress, Rapid breathing, Cyanosis, Abnormal breath sound, Generalized Hypotonia, Increased serum CK, Myopathy, Respiratory failure)

      HPOsFreeText: Intercostal and subcostal retraction, Diffuse infiltrative process involving the left lung field, CK rate was 3 times the normal value and AST and ALT were 2 times the normal value, GAA activity was deficient

      CaseNotHPOs: HP:0030148, HP:0011675, HP:0001315, HP:0001291, HP:0003115 (Heart murmur, Arrhythmia, Decreased/absent deep tendon reflexes, Cranial nerve abnormality, Abnormal ECG)

      CaseAddInfo: Proband was the second born child of healthy consanguineous parents, Pregnancy was uneventful,

    1. PD16

      Patient16: Male, Northern China

      CasePresentingHPOs:

      HPOsFreeText: IOPD

      CaseNotHPOs:

      NotHPOsFreeText:

      CaseAddInfo:

      CasePMIDs:

      CasePreviousTesting: same as group

      CaseGenotypingMethod: same as group

      Variant1: NM_000152.4(GAA):c.2662G>T (p.Glu888Ter)

      ClinVar: 578595, https://www.ncbi.nlm.nih.gov/clinvar/variation/578595/

      gnomAD: 1.65e-05, http://exac.broadinstitute.org/variant/17-78092467-G-T

      Variant2: NM_000152.3:c.1597T>G

      CAID: CA401367282, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA401367282

      gnomAD: n/a

    2. PD03

      Patient3: Male, northern China

      CasePresentingHPOs:

      HPOsFreeText: IOPD

      CaseNotHPOs:

      NotHPOsFreeText:

      CaseAddInfo:

      CasePMIDs:

      CasePreviousTesting: same as group

      CaseGenotypingMethod: same as group

      Variant1: NM_000152.3:c.2024A>G

      CAID: CA401370120, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA401370120

      gnomAD: n/a

      Variant2: NM_000152.4(GAA):c.2132C>G (p.Thr711Arg)

      ClinVar: 381006, https://www.ncbi.nlm.nih.gov/clinvar/variation/381006/

      gnomAD: 0.0001488, http://exac.broadinstitute.org/variant/17-78087108-C-G

    1. PD/Pathogenic-6

      CasePD/Pathogenic-6: 4 weeks diagnosis

      HPOsFreeText: GAA activity 8.8 (nmol · h−1 · mg−1), Mean percentage of normal 12.3%

      GenotypingMethod: Newborn Screening Panels


      Variant1: NM_000152.4:c.1726G>A (p.Gly576Ser)

      ClinVar: 92467 https://www.ncbi.nlm.nih.gov/clinvar/variation/92467/

      gnomAD: East Asian 0.1427, Overall 0.01700 http://gnomad.broadinstitute.org/variant/17-78085871-G-A


      Variant2: NM_000152.4:c.2065G>A (p.Glu689Lys)

      ClinVar: 4030 https://www.ncbi.nlm.nih.gov/clinvar/variation/4030/

      gnomAD: East Asian 0.2355, Overall 0.05524 http://gnomad.broadinstitute.org/variant/17-78087041-G-A


      Chromosomal code not provided

      Variant3: NP_000143.2:p.N87Tfs*55

      ClinVar: N/A

      gnomAD: N/A


      CaseAddInfo: Patient has one pseudodeficency allele and one pathogenic allele, Nomenclature claims Variant 1 and 2 are in cis

    2. PD/VOUS-3

      CasePD/VOUS-3: 2 weeks diagnosis

      HPOsFreeText: GAA activity 11.3 (nmol · h−1 · mg−1), Mean percentage of normal 15.8%

      GenotypingMethod: Newborn Screening Panels


      Variant1: NM_000152.4:c.1726G>A (p.Gly576Ser)

      ClinVar: 92467 https://www.ncbi.nlm.nih.gov/clinvar/variation/92467/

      gnomAD: East Asian 0.1427, Overall 0.01700 http://gnomad.broadinstitute.org/variant/17-78085871-G-A


      Variant2: NM_000152.4:c.2065G>A (p.Glu689Lys)

      ClinVar: 4030 https://www.ncbi.nlm.nih.gov/clinvar/variation/4030/

      gnomAD: East Asian 0.2355, Overall 0.05524 http://gnomad.broadinstitute.org/variant/17-78087041-G-A


      Variant3: NM_000152.4:c.664G>A (p.Val222Met)

      ClinVar: 290223 https://www.ncbi.nlm.nih.gov/clinvar/variation/290223/

      gnomAD: South Asian 5.393e-3, Overall 6.931e-4 http://gnomad.broadinstitute.org/variant/17-78079665-G-A


      CaseAddInfo: Patient has one pseudodeficency allele and one allele of uncertain significance, Nomenclature claims Variant 1 and 2 are in cis

    1. 1

      Case#: Patient 1, female, 2.5 months of age at diagnosis, Hispanic

      DiseaseAssertion: Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001638, HP:0032988, HP:0001252, HP:0001270, HP:0002015, HP:0012378

      (Cardiomyopathy, Persistent head lag, Muscular hypotonia, Motor delay, Dysphagia, Fatigue)

      CaseHPOFreeText: NG tube feeding was left after Enzyme Replacement Therapy (ERT).

      Cardiac status at base line was 160 LVMI g/m^2, after ERT IT WAS 81 LVMI g/m^2

      Patient needed oxygen at baseline, no respiratory support at ERT.

      one episode of Infusion Associated Reactions (IARs) to ERT.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting:

      Variant 1: NM_000152.5(GAA):c.2608C>T (p.Arg870Ter)

      ClinVar: 189009

      CAID: CA274250

      gnomAD: Highest population MAF= 0.00004888 (European non-Finnish)

      ParentalGenotype:N/A

      PreviouslyPublished:N/A

    1. Ten patients received concomitant immunomodulation (detailed in Supplementary Table S4); six were genotype-predicted as CRIM-negative, three were CRIM-positive, and one lacked genotype data.

      Patient 3

      Variant1: NM_000152.3:c.2481+102_2646+31del

      CAID: CA658795291, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.3%3Ac.2481%2B102_2646%2B31del

      gnomAD: n/a

      Variant2: NM_000152.4(GAA):c.307T>G (p.Cys103Gly)

      ClinVar: 92483, https://www.ncbi.nlm.nih.gov/clinvar/variation/92483/

      gnomAD: n/a

    1. PATIENT 1

      Case#: Patient 1, woman, 58 years old, ethnicity unknown

      DiseaseAssertion:Pompe disease

      Was also misdiagnosed with adult-onset spinal muscular atrophy (SMA)

      FamilyInfo: No family history of muscle disease

      CasePresentingHPOs: HP:0003701, HP:0100284

      (Proximal muscle weakness, EMG myotonic discharges)

      CaseHPOFreeText: Denervation atrophy from a muscle biopsy

      Weakness of hip flexion 2–3/5, hip abduction 2/5, and hip adduction 2/5

      Myotonic discharges were in the lumbar paraspinals, vastus medialis, and tensor fasciae latae muscles.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: GAA enzyme activity assay was 1 pmol/punch/h (normal range 10–49 pmol/punch/h)

      Her creatine kinase (CK) level at presentation had been elevated as high as 429 U/L (normal range 45–145)

      Found with two mutations in the GAA gene

      Variant: NM_000152.5(GAA):c.-32-13T>G

      ClinVar: 4027

      CAID: CA116606

      gnomAD: Highest population MAF= 0.005541 (Ashkenazi Jewish)

      Variant: NM_000152.5(GAA):c.525del (p.Glu176fs) Double check this variant

      ClinVar: 4033

      CAID: CA220406

      gnomAD: N/A

      ParentalGenotype:N/A

      Previously Published: N/A

    1. Subject II-6

      Subject II-6: female, 56yo

      CasePresentingHPOs: HP:0000822, HP:0003701, HP:0001611, HP:0003691, HP:0003700, HP:0009023, HP:0003307, HP:0002515, HP:0040081, HP:0003458

      HPOsFreeText: altered DBS, treated with beta-blockers, occasional cramping of lower limbs, muscle atrophy of temporal, deltoids, and thigh muscle extensors, muscle strength was 5/5 proximal and distal for upper limbs and distal for lower limbs, and 4/5 on hip extension, diminished biceps, triceps, patellar, and ankle jerk reflexes. Intact pain, temperature, vibration, proprioception, and coordination. CK = 86 IU/L, AST = 33 IU/L, reduced GAA activity, reduced duration and amplitude of motor unit action potentials (mainly on thigh extensors), normal muscle biopsy

      CaseNotHPOs: HP:0001291, HP:0002015, HP:0001618, HP:0003391, HP:0003487

      NotHPOsFreeText: no Hoffmann sign, paraspinal complex repetitive discharges

      CaseAddInfo: This patient's 5 daughters had DBS and GAA sequencing evaluations, only 2 (III-9 and III-10) had altered DBS and carried GAA variants

      CasePMIDs:

      CasePreviousTesting: DBS, EMG, muscle biopsy from thigh extensors

      CaseGenotypingMethod: GAA genotyping

      Variant1: NM_000152.4(GAA):c.-32-13T>G

      Clinvar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/

      gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G

      Variant2: NM_000152.4(GAA):c.2560C>T (p.Arg854Ter)

      ClinVar: 4034, https://www.ncbi.nlm.nih.gov/clinvar/variation/4034/

      gnomAD: 0.0002090, http://gnomad.broadinstitute.org/variant/17-78092070-C-T

    1. 4

      Patient4: Female

      CasePresentingHPOs: HP:0004887, HP:0002194, HP:0001522

      HPOsFreeText: ERT dosage = 20 mg/kg/2 w, able to hold objects, CRIM negative

      CaseNotHPOs:

      NotHPOsFreeText: no reversal of HCM

      CaseAddInfo: Symptom onset and diagnosis at 2mo, ERT at 3.5mo, ERT lasted for 8mo, ventilation required at 11mo, died at 12mo

      CasePMIDs: 22252923, 27629047

      CasePreviousTesting: same as group

      CaseGenotypingMethod: same as group

      Variant: NM_000152.3:c.1657C>T

      CAID: CA401368835, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.3%3Ac.1657C%3ET

      gnomAD: n/a

    1. 20

      Case#: Subject number 20, female, 29 years (diagnosis), 40 years (baseline visit), 40 years (ERT), 39 (age at ventilation)

      DiseaseAssertion: Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001324 (Muscle Weakness), HP:0002098 (respiratory distress)

      CaseHPOFreeText: mechanical ventilation at Baseline Visit, mechanical ventilation at last visit

      CaseNotHPOs: HP:0003236 (Elevated circulating creatine kinase concentration), HP:0002870 (obstructive sleep apnea)

      CaseNotHPOFreeText:

      CasePreviousTesting: "reduced enzymatic activity on fibroblasts, blood leukocytes or skeletal muscle and/or the presence of two known mutations in the GAA gene"

      PreviouslyPublished: N/A

    2. 26

      Case#: Subject number 26, male, 35 years (diagnosis), 51 years (baseline visit), 51 years (ERT), 49 (age at ventilation)

      DiseaseAssertion: Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001324 (Muscle Weakness), HP:0002098 (respiratory distress)

      CaseHPOFreeText: mechanical ventilation at Baseline Visit, mechanical ventilation at last visit

      CaseNotHPOs: HP:0003236 (Elevated circulating creatine kinase concentration), HP:0002870 (obstructive sleep apnea)

      CaseNotHPOFreeText:

      CasePreviousTesting: "reduced enzymatic activity on fibroblasts, blood leukocytes or skeletal muscle and/or the presence of two known mutations in the GAA gene"

      PreviouslyPublished: N/A

    3. 15

      Case#: Subject number 15, female, 35 years (diagnosis), 51 years (baseline visit), 46 years (ERT), 46 (ventilation)

      DiseaseAssertion: Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001324 (Muscle Weakness), HP:0002098 (respiratory distress)

      CaseHPOFreeText: mechanical ventilation at Baseline Visit, mechanical ventilation at last visit

      CaseNotHPOs: HP:0003236 (Elevated circulating creatine kinase concentration), HP:0002870 (obstructive sleep apnea)

      CaseNotHPOFreeText:

      CasePreviousTesting: "reduced enzymatic activity on fibroblasts, blood leukocytes or skeletal muscle and/or the presence of two known mutations in the GAA gene"

      PreviouslyPublished: N/A

    4. 24

      Case#: Subject number 24, female, 42 years (diagnosis), 57 years (baseline visit), 55 years (ERT), 54 (age at ventilation)

      DiseaseAssertion: Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001324 (Muscle Weakness), HP:0002098 (respiratory distress)

      CaseHPOFreeText: mechanical ventilation at Baseline Visit, mechanical ventilation at last visit

      CaseNotHPOs: HP:0003236 (Elevated circulating creatine kinase concentration), HP:0002870 (obstructive sleep apnea)

      CaseNotHPOFreeText:

      CasePreviousTesting: "reduced enzymatic activity on fibroblasts, blood leukocytes or skeletal muscle and/or the presence of two known mutations in the GAA gene"

      PreviouslyPublished: N/A

    5. 27

      Case#: Subject number 27, male, 35 years (diagnosis), 51 years (baseline visit)

      DiseaseAssertion: Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001324 (Muscle Weakness)

      CaseHPOFreeText:

      CaseNotHPOs: HP:0003236 (Elevated circulating creatine kinase concentration), HP:0002870 (obstructive sleep apnea), HP:0002098 (respiratory distress)

      CaseNotHPOFreeText: no mechanical ventilation at Baseline Visit, no mechanical ventilation at last visit

      CasePreviousTesting: "reduced enzymatic activity on fibroblasts, blood leukocytes or skeletal muscle and/or the presence of two known mutations in the GAA gene"

      PreviouslyPublished: N/A

    1. 4

      Case#: Patient 4, male, diagnosed 2015 (not given age of diagnosis), age 42 during study period

      DiseaseAssertion: Pompe Disease

      FamilyInfo: None given

      CasePresentingHPOs: None given

      CaseHPOFreeText: None given

      CaseNotHPOs: None given

      CaseNotHPOFreeText: None given

      CasePreviousTesting: None given

      Variant 1: NM_000152.5:c.-32-13T>A (unclear variant nomenclature)

      Variant 1 ClinVarID: N/A

      Variant 1 CAid: CA913184742

      Variant 2: NM_000152.5:c.525del

      Variant 2 ClinVarID: 4033

      Variant 2 CAid: CA220406

      ParentalGenotype: Not provided

    2. 3

      Case#: Patient 3, female, diagnosed 2015 (not given age of diagnosis), age 40 during study period

      DiseaseAssertion: Pompe Disease

      FamilyInfo: None given

      CasePresentingHPOs: None given

      CaseHPOFreeText: None given

      CaseNotHPOs: None given

      CaseNotHPOFreeText: None given

      CasePreviousTesting: None given

      Variant 1: NM_000152.5:c.-32-13T>G (unclear variant nomenclature, homozygous)

      Variant 1 ClinVarID: 4027

      Variant 1 CAid: CA116606

      ParentalGenotype: Not provided

    1. 1/F

      Patient1: Female, Caucasian, 10yo

      CasePresentingHPOs:

      HPOsFreeText: IOPD, rhGAA IgG antibody titer = 400, CRIM positive

      CaseNotHPOs:

      NotHPOsFreeText: no infusion associated reactions

      CaseAddInfo: homozygous, 6.5mo at diagnosis, 7.0mo at ERT start

      CasePMIDs:

      CasePreviousTesting: same as group

      CaseGenotypingMethod: same as group

      Variant: NM_000152.4(GAA):c.655G>A (p.Gly219Arg)

      ClinVar: 189065, https://www.ncbi.nlm.nih.gov/clinvar/variation/189065/

      gnomAD: 0.00001809, https://gnomad.broadinstitute.org/variant/17-78079656-G-A

    1. 2

      Case#: Patient 2

      DiseaseAssertion: Pompe Disease

      FamilyInfo: None given

      CasePresentingHPOs: None

      CaseHPOFreeText: None

      CaseNotHPOs: None

      CaseNotHPOFreeText: None

      CasePreviousTesting: Single gene sequencing with Ion Torrent Persional Genome Machine

      Glucosidase activity: 0.0 nmol 5MU/hr/mL

      Variant 1: NM_000152.5:c.596A>G

      Variant 1 ClinVarID: 92486

      Variant 1 CAid: CA145785

      Variant 2: NM_000152.5:c.668G>A

      Variant 2 ClinVarID: 92488

      Variant 2 CAid: CA145791

      ParentalGenotype: Not provided

    1. 23

      Case#: P 23, Female, 4.7 months old when started ERT (45.8months old when last reported), German

      DiseaseAssertion: Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 , HP:0001252 , HP:0003701, HP:0006532, HP:0002650

      (Hypertrophic cardiomyopathy, Muscular hypotonia, Proximal muscle weakness, Recurrent Pneumonia, Scoliosis)

      CaseHPOFreeText: Scoliosis and recurrent pneumonia were complications during ERT

      No motor activity achieved

      Requiered ventilation and tube feeding

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      Variant: NM_000152.3:c.1456G>C (p.Ala486Pro)

      ClinVar: N/A

      CAID: CA401366835

      gnomAD: N/A

      ParentalGenotype: Both the paternal and maternal allele carried the NM_000152.3:c.1456G>C Variant

      PreviouslyPublished:N/A

    2. 22

      Case#: P 22, Female, 0.2 months old when started ERT (47.0 months old when last reported), German

      DiseaseAssertion: Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 , HP:0001252 , HP:0003701, HP:0001371

      (Hypertrophic cardiomyopathy, Muscular hypotonia, Proximal muscle weakness, Flexion contracture )

      CaseHPOFreeText: Flexion contractures were a complication during ERT

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: No tube feeding nor ventilation needed

      CasePreviousTesting: CRIM status is unknown

      Antibody titer is 1:1.800

      Variant 1: NM_000152.3:c.2004C>A

      ClinVar: N/A

      CAID: CA401370054

      gnomAD: N/A

      Variant: c.541545delTTAC

      ClinVar: N/A

      CAID: N/A

      gnomAD: N/A

      ParentalGenotype: Maternal allele carried the c.2004 C>A Variant

      The paternal allele carried the c.541545delTTAC

      PreviouslyPublished: N/A

    1. Patient 2 was a 29-year old Caucasian male

      Patient2: female, 29 yo, Caucasian

      CasePresentingHPOs: HP:0003724, HP:0008988, HP:0003691, HP:0003391, HP:0003551, HP:0040081, HP:0002910, HP:0003557, HP:0100295, HP:0100295, HP:0009051, HP:0004356, HP:0002111

      HPOsFreeText: paravertebral muscle atrophy, atrophies with paresis grade of 3-4 MRC, cannot stand from squatting position, impaired overhead work, CK = 1390 U/l, AST = 65 U/l, ALAT = 72 U/L, symmetrical atrophy of thigh muscle, fatty deposits in m. adductor magnus, flause signal elevation in the mm. semimembranosus and mm. biceps femoris bilateral, reticulation in the proximal vastus intermedius and vastus lateralis, vacuolated muscle fibres, PAS-positive glycogen storage with enhanced lysosomal activity in the PAS staining, increased lysosomal activity, GAA activity = 0.22nmol/spot x 21hrs

      CaseNotHPOs: HP:0001639

      CaseAddInfo:

      CasePreviousTesting: MRI of thigh muscle, muscle biopsy of mm. vastus lateralis, hematoxylin and eosin stain, Peri acid-Schiff reaction, Acid phosphatase staining, transthoracic echocardiogram, respiratory function test

      CaseGenotypingMethod: Sanger Sequencing

      Variant: NM_000152.4(GAA):c.-32-13T>G

      Clinvar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/

      gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G

    1. P1

      PatientF1P1: Female, 30 years onset, 40 years diagnosis, Caucasian

      CasePresentingHPOs: HP:0007340, HP:0002172 (Leg weakness, Postural instability)

      HPOsFreeText: History of hyperCKemia greater than 1,000 U/L (control 30–220 U/L), Showed deficient muscle acid GAA activity (0.05 µmol/min/g, control >0.42 µmol/min/g)

      CaseAddInfo: First cousin twice removed of F1P3, Proband

    1. Case 1

      Case#: Case 1, Boy, Death at 6-7 months old, Hispanic

      DiseaseAssertion: Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0002240, HP:0001640, 0000961, HP:0002090, HP:0001270, HP:0031664, HP:0200128, HP:0001252

      (Hepatomegaly, Cardiomegaly, Cyanosis, Pneumonia, Motor delay, Systolic heart murmur, Biventricular hypertrophy, Muscular Hypotonia)

      CaseHPOFreeText: Heart failure, Systolic murmur grade II-III, Enlarged, EKG showed an inverted T wave from V4-V6 as well as AVF, suggesting left systolic overload.

      CaseNotHPOs:

      CaseNotHPOFreeText:

      CasePreviousTesting: Ejection fraction of 52%

      Serum creatine kinase was 386 IU/L (mildly elevated)

      GAA activity on dried blood spot was decreased (1.08 nmol/L; normal range: 1.5-10 nmol/L)

      Whole exon and exon-intron boundaries direct sequencing revealed a homozygous single base deletion c.1987delC

      Variant: c.1987delC

      ClinVar: N/A

      CAID: N/A

      gnomAD: N/A

      ParentalGenotype: N/A

      PreviouslyPublished: N/A